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ABSTRACT
Alcohol dehydrogenase (ADH, alcohol:NAD oxidoreductase, 
EC1.1.1.1) from Drosophila melanogaster (DmADH) is unique among 
alcohol dehydrogenases in metal ion requirement, substrate 
preference, and stereospecificity of hydride transfer. In 
order to study this unique enzyme, the first part of this 
dissertation reports the construction and expression of DmADH 
cDNA in E. coli hosts.
The second part of the dissertation shows the structural 
function of glycine-14 in putative NAD-binding domain of DmADH. 
The comparison of DmADH to horse liver ADH suggests that 
glycine-14 in DmADH is located at the first position of a 
"conserved sequence" which maintains the tight turn structure 
positioned in the NAD-binding domain. Mutating glycine 14 to 
valine virtually inactivates DmADH and alanine substitution 
causes a decrease in activity. Thermal denaturation, kinetic, 
and inhibition studies confirm that replacing glycine-14 with 
either alanine or valine leads to structural changes in the 
NAD-binding domain. These results provide direct evidence for 
the role played by glycine-14 in maintaining correct 
conformation in the NAD-binding domain.
The third part of the dissertation concerns two cysteinyl 
residues. DmADH is sensitive to DTNB which modifies one of the 
two cysteinyl residues in the enzyme. In order to identify the 
reactive cysteinyl residue and investigate its functional 
significance, one or both of the two cysteinyl residues has 
been changed to alanine (CA135, CA218 and CA135/CA218). None
x
of the mutants show decreased specific activity relative to 
wild-type, indicating that neither of the cysteinyl residues is 
essential for catalysis. CA135 and wild-type enzyme are both 
inactivated by DTNB, but CA218 and CA135/CA218 are unaffected 
by DTNB treatment, suggesting that DTNB introduces a steric 
interference at cysteine-218. DTNB modification of cysteine 
can be prevented by the substrates, NAD and 2-propanol, 
indicating that cysteine-218 may be in the vicinity of the 
active site. Cysteine-135 which is normally insensitive to 
DTNB becomes accessible in the presence of isopropanol and NAD, 
suggesting a conformational change induced by binding to these 
substrates.
xi
CHAPTER OMB 
XMTRODOCTCOtf
1.1 Background
Drosophila melanogaster alcohol dehydrogenase (DmADH) 
(alcohol:NAD oxidoreductase, EC1.1.1.1) reversibly catalyzes 
the conversion of alcohols to their oxidation products, 
aldehydes and ketone. In addition, several studies (Moxon et 
al., 1985; Eisses et al., 1985) have suggested that DmADH also 
uses acetaldehyde as a substrate for further oxidation. These 
facts are consistent with the physiological functions of DmADH 
in utilizing and detoxifying dietary alcohol. Since the major 
food of Drosophila, a fruit-fly, may contain high 
concentrations of alcohols, DmADH, therefore, is very abundant, 
forming up to 2% of total soluble protein in Drosophila 
melanogaster. DmADH is a small protein of 255 amino acid 
residues. It is a homo-dimer with a subunit molecular weight 
of approximately 27 KDa (Schwartz et al., 1979; Thatcher 6 
Sawyer, 1980) .
DmADH has been the focus of a large research effort for 
over twenty years. In the mid-1960s, three laboratories (Grell 
et al., 1965; Johnson & Denniston, 1964; and Ursprung & Leone, 
1965) independently reported the discovery of ADH activity in 
extracts of Drosophila melanogaster. Four years later, the 
enzyme was purified by Sofer and Ursprung (1968). The DmAdh 
gene was isolated by Maniatis et al. (1978) and Goldberg
1
2(1980). Although gene Isolation occurred ten years after the 
protein product was Isolated, most of the current publications 
on DmADH relate to the structure and regulation of this gene. 
The structure of DmAdh has been well established (Fig.l) 
(Benyajati et al., 1981; 1963; Sofer £ Martin, 1987). DmADH 
is encoded by a single gene containing two small introns (65 
and 70 bp) within the coding region. However, the protein is 
translated from two different mRNAs, which are transcribed from 
two different promoters during fly development: the distal 
(adult) promoter and the proximal (embryonic-larval) promoter. 
As a result of this feature, DmADH activity rises slowly during 
larval life, falls to a very low level during pupation, and 
rises immediately to a new high level early in adult life 
(Savakis & Ashburner, 1985). DmADH expression shows not only 
timing but also tissue specificity. It has been determined 
that ADH activity is significantly higher in both larval and 
adult fat bodies than in other tissues. The cis-acting DNA 
elements necessary for correct developmental programming of 
DmAdh are contained in the DNA region 5' and 3' to the coding 
sequence (Benyajati et al., 1987; Fischer £ Maniatis, 1988). 
The corresponding trans-acting factors have also been studied 
(Heberlein et al., 1985).
Compared to the molecular biological studies of Adh gene 
and its expression, biochemical analyses of DmADH are 
relatively rare. Thus far, studies on structure-function 
relationships in DmADH have been based on the primary sequence 
of the protein. Most data used to address this issues were
3derived from studies on natural DmADH variants and chemical or 
x-ray induced mutants. These approaches are limited by the 
facts that first, only a few ADH nulls are identified and 
characterized (see Table 2 for a list) and second, the 
enzymology of these proteins is understood only partially 
(Table 4) or not at all. Therefore, the objective of this 
dissertation is to investigate the structure-function 
relationships of DmADH by a new technique, site-directed 
mutagenesis.
1.2 Structural Properties of DmADH
1.2.1 Genetic Variation of DmADH and Chemical or X-
ray Induced Mutants
One remarkable feature of DmADH is its biochemical 
polymorphism. Natural populations carry predominantly two 
electrophoretic forms (allozymes) of the enzyme: ADH-F and ADH- 
S (for fast and slow migration on SDS-PAGE). A list of Adh 
alleles known to encode active enzyme forms is given in Table 1 
(Chambers, 1988; Ashburner, 1985). The variants listed show 
not only different electrophoretic mobilities on SDS-PAGE, but 
also different thermal stabilities and catalytic activities 
which will be discussed in Section 1.3.3. Amino acid 
sequencing of some variants indicates that only one or two 
amino acid differences in primary sequence exist, providing the 
useful probes to examine the structure-function relationship of 
DmADH.
Another way to locate critical structural portions for 
DmADH activity is to analyze ADH null (no activity) mutants 
generated by random mutagenesis (as distinguished from site- 
directed mutagenesis). Common methods used to induce mutants 
include x-radiation and chemicals such as ethyl 
methanesulfonate (EMS) and formaldehyde. A conditional lethal 
screening procedure for DmADH nulls invented by Sofer and 
colleagues (1972) makes the selection of mutants possible. 
Drosophila containing putative Adh null alleles are exposed to 
an unsaturated secondary alcohol. Such alcohols can be rapidly 
oxidized to highly toxic unsaturated ketones in ADH-positive 
flies. Thus, only those individuals lacking ADH activity can 
survive the selection. Over the past two decades, more than 
fifty DmADH nulls have been reported (Kelley et al., 1985;
Place et al., 1987; Hollochor & Place, j.987; Lee, personal 
communication). Thirteen of these have been sequenced (Table 
2). Since the amino acid substitutions induced by chemicals 
and x-radiation are random, studies based on these mutants are 
insufficient to determine their structural significance.
5Fig. 1
Exon I Exon 2  Exon 3 E x o n  4 3*
L a r v a l  l e a d e r  
s e q u e n c e
\S£
100 BP
TAA
Adult  l e a d e r  P r o l e i n ^ e n c o d i n g  
s e q u e n c e  r e g io n
3* U n t r a n s l a t e d  
r e g i o n
P o ly o d e n y l o t i o n
s i t e
Diagram of tha DmAdh locua showing introns, axons, 
larval and adult: laadar saquancas, mRNA start sita 
and poly A sita as indicatad (Kraitman, 1983).
‘Table 1.
Allallc Variants of tha DmAdh Gana
Amino acid
Description of substitution
Variant phenotype Source (relative to ADH-S)“
ADH-US Ultra-slow mobility  
variant
Africa* —
ADH-Ss Heat-sensitive enzym e  
with ADH-S  
mobility
N, America'
ADH-S Standard ADH-S Worldwide*' Standard
ADH-F Standard A DH-F Worldwide*' Lys 192 Thr
ADH-Fi Heat-stable enzym e  
with ADH F 
mobility
N. America'
ADH-7IK Laboratory
stock' Lys 192 - •  Thr* 
Pro 214 —* Ser
ADH-FCh U Australia* Lys 192 —* Thr* 
Pro 214 —• Ser
ADH-Fs Heat-sensitive enzym e  
with ADH-F  
mobility
N. America'
ADH FR City Unstable enzym e N. America1 ...
A D H -F ’ Stable enzyme with  
mobility s lightly  
greater than ADH-F
Africa* > I c
ADH-IJF Ultra-fast mobility  
variant
Spain' Asm K —* Ala 
Ala 45 — Asp 
Lys 1 9 2 — Thr
ADH-D Ultra-liisl mobility Laboratory Lys 192 — Thr
mutant induced* n iy  232 — Cily
ADH-AI Kecoinbinants Laboratory
cross'
ADH-B7 —
" A f l e r  A s h h u r n e r  r 1985) Heferences are also given in the text for ammo acul replacement data
* David et til < 1980
Sampsell f 19771 m
* K reilm an ( 1980i
'  K Th Kisses 'personal comm unication)
' Tilling rl al G975
* G ibson et ut 11980'
* Protein sequence da la (Chambers et a l ,  1981a) have been confirmed by DNA sequencing 
fC Collet, personal communication)
' F letcher (unpublished); see C ham bers et al. (1984b).
‘ M alpica and Briscoe (unpublishedI; see T ha tcher (1977).
‘ G rell et al. (1968)
1 M aroni (19781
This table is adopted from Chambers (1988)
Table 2. 
Nigiana* and Deletion Mutations of Padtdh
7
Mutations Mutagenic Position* Sequence Changes Ref.
Agent
Leel EMS 105 Thr - H e a
Lee 2 EMS 117 Gly - Asp a
Lee3 EMS 166 Ser - Phe a
Lee 4 EMS 168 Ala - val a
Lee 5 EMS 168 Thr - lie a
Lee6 EMS 235 Trp - Arg a
Adh"11 EMS 14 Gly - Asp b
Adhn“ EMS 235 Trp - stop c
Adhfn4 Formaldehyde Intron 2 17 bp deletion d
Adhf0‘ Formaldehyde Intron 2 6 bp deletion d
Adh(n” Formaldehyde 241 34 bp deletion d
A dh,na4 Formaldehyde 63 11 bp deletion d
Lee 7 X-ray 183 Pro — Arg a
Lee, personal communication.
Thatcher, 1980.
Martin et al., 1985.
Benyajati et al., 1983.
Serine is counted as the No.l residue.
1.2.2 DmADH Primary Sequence and A Pradlotad
Secondary Structura
The primary sequence of DmADH has been fully determined 
(Thatcher, 1980) and confirmed by DNA sequencing (Goldberg, 
1988; Benyajati et al., 1980; 1981; Kreitman, 1983) (Appendix 
I). Comparing the primary sequence of DmADH with ADHs from 
other sources reveals no overall sequence homology. However, 
hypothetical secondary structure predictions using Chou-Fasman 
programs (1975) show an NAD-binding domain with a similar 
pattern to that of horse liver ADH (LADH) at the N-terminus of 
the DmADH molecule (Benyajati et al., 1981; Thatcher & Sawyer 
1980) (Appendix II). The NAD-binding domain consists of 
alternating o<-helixes and ^ -sheets (Fig. 2 & 3), a structural 
feature which is common to the NAD-binding domain of many NAD- 
dependent dehydrogenases (Rossmann, 1983). The N-terminal 
region of the NAD binding fold contains the sequence 
GlyXGlyXjGly (X ** any residue) . This "conserved sequence" 
(Argos & Leberman, 1985) characteristically marks the tight 
turn following the first g-sheet of the NAD-binding domain in 
NAD-dependent dehydrogenases (Table 3). This "conserved 
sequence" has been reported in kinases (Walker et al., 1982) 
and oncoproteins (Sternberg & Taylor, 1984) as well as in 
dehydrogenases.
In DmADH the first glycine residue in the "conserved 
sequence" is glycine-14. ADH isolated from the ADH"11 mutant 
(Section 1.2.1) contains an aspartic acid substitution at 
position 14. This mutant shows no ADH activity (Thatcher,
91980) and has a low affinity for NAD (Place et al., 1979). It 
has been suggested that aspartic acid substitution probably 
disturbs the tight turn in the putative NAD-binding domain. 
However, it is unclear whether inactivation is due to the size 
or negative charge of the aspartic acid..
Little progress on structure-function analysis of DmADH 
has been made due to the lack of x-ray crystallographic studies 
on the protein. However, a recent review by Chambers (1988) 
reports that small ADH-F crystals have been isolated which show 
a threefold screw axis of symmetry.
10
Table 3.
Alignment of "Conserved Sequence" in NAD-dependent 
Dehydrogenase
Protein Residues Sequences
GAPDH 1-20 SKIGIDOFORIORLVLRAAL
LDH 21-40 NKITWGVGAVGMACAISIL
LADH 193-212 STCAVFOLGGVOLSVIMGCK
DmADH 8-27 NVIFVAGLGGIGLDTSKELL
GAPDH: Glyceraldehyde-3-phosphate; LDH: Lactate 
dehydrogenase; LADH: Liver alcohol dehydrogenase; DmADH: 
Drosophila alcohol dehydrogenase.
11
Fig. 2 Th« NAD-binding Domnin Common to NAD-dnpondont
Dnhydrognnaaaa (Roaamann, 1983).
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Aden me* m ononucleotide b ind in g  domain
Horse LADH s t c * v f  ■  l g g < | [  i  v , w u m t ,  • * n
U.tn. ADH iGO'li d i  s u  1 1  i « d  l k n i  v  i l B p  i i  n  p  a  a  ■ a  e . k a i n p k v t v t p y p y
N i c o t i n a m i d e  m o n o n u c l e o t i d e  b i n d i n g  d o m a i n  
__________& _   ft_  f*
9H B S
H o r s e  L A D H | G  g " l o t m v t a l s c c o t a v g v s v i v g  v p p o s o n . s m n  p m l i c s  g *t w a g  a i
D.tn A D H  | o  i ^ v d i ^ i n §  a  & i i d d k q  i e a t  h v n h  g  l w n t  t t a i  l o f w C ' * h k g g p & g i  y t
Fig. 3 Comparison of NAD-binding Domain of Horaa LADH with
tha Fradictad NAD-binding Ragion of DmADH (Banyajati 
at al. , 1981) .
E G
G
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1.2.3 Struetuxe-funetion Analysis from Isomyms
Convention and Ch— leal Modification
Electrophoresis of total protein extracts of homozygous 
flies of any Adh genotype produces two or three isozymic 
staining regions (ADH-5, ADH—3, and ADH-1, in the order of 
anodal migration). The origin of these forms is well 
understood. They arise from the binding of zero, one, or two
molecules of an NAD-carbonyl adduct per ADH dimer (Schwartz et
al., 1979 and Winberg et al. 1968a). By using gel 
electrophoresis in the presence of coenzyme, Winberg et al. 
(1983) studied isozyme conversion in pure ADH-S (slow allele). 
They found that at least one of the multiple forms of purified 
DmADH appeared during purification. This enzyme fraction can 
not be converted into an NAD-carbonyl containing enzyme, even 
if incubated with NAD and acetone. It is probably a deamidated 
form of DmADH as suggested by Thatcher (1980). At least one of 
labile amides in DmADH is located in the coenzyme binding
region which prevents NAD binding.
In addition to studying the function of the labile amides 
in DmADH, two cysteinyl residues have been examined by chemical 
modification. In general, cysteinyl residues are considered to 
be potential catalytic site in enzymes because of the 
nucleophilic nature of the sulfhydryl group. In previous 
studies on DmADH (Thatcher, 1981 and Chambers et al., 1981), it 
has been found that this dimeric enzyme contains two cysteinyl 
residues per monomer, cysteine-135 and cysteine-218. In the 
native enzyme, one cysteinyl residue reacts rapidly with 5,5'-
dithiobis(2-nitrobenzoate) (DTNB) causing a loss of ADH 
activity. The other cysteinyl residue is almost unreactive 
toward DTNB in the native enzyme. Chambers et al. (1981) 
suggested that cysteine-135 was the DTNB-reactive residue and 
found that after chemical modification by iodoacetamide , most 
of cysteine-218 was recovered as an unmodified cysteine. 
However, cysteine-135 was never recovered from modified enzyme 
for a conclusive identification because this residue was 
located in a large hydrophobic peptide region. On the other 
hand, Thatcher (1981) indicated that this enzyme was resistant 
to alkylation with iodoacetic acid or iodoacetamide.
Therefore, chemical modification alone has been insufficient to 
determine the function and to identify of the cysteine which is 
sensitive to DTNB.
1.2.4 Structural Information from Substrata
Specificity and Inhibition Behaviors
X-ray crystallographic studies of LADH suggest that the 
alcohol binding site contains one hydrophobic funnel to which 
the alkyl group of the primary alcohol binds preferentially 
(Eklund et aJ., 1976). This structure has also been suggested 
for yeast ADH which, in contrast to LADH, is more active toward 
ethanol than larger alcohol such as n-butanol. This indicates 
the existence of a larger hydrophobic funnel in LADH than in 
yeast ADH.
On the other hand, DmADH is quite different from LADH and 
yeast ADH. It prefers secondary alcohols as substrates (Sofer
15
& Ursprung, 1968; Winberg et a J., 1982a). The difference in 
substrate specificity between DmADH and LADH or yeast ADH 
indicates that there are substantial differences in the 
alcohol-binding sites. Its high activity toward secondary 
alcohol suggests that DmADH may bind both alkyl groups of the 
substrate through hydrophobic residues. In substrate 
specificity studies, identical vm and Km values for the two 
enantiomers of 2-butanol support this idea. If the hydrophobic 
interaction between enzyme and substrate involved only one of 
the two alkyl groups of 2-butanol, as in LADH or yeast ADH, 
only the ethyl group in one enantiomer or the methyl group of 
the other should bind to the hydrophobic site of the enzyme.
In such a case, large differences in Vm/Km between the two 
enantiomers should be observed; this is not the case in DmADH.
In inhibition studies, chemical compounds which are known 
to be good inhibitors of LADH have been used with DmADH 
(Winberg et al., 1982b). Salicylate is a coenzyme-competitive 
inhibitor of dehydrogenases (Dawkins et al., 1967). It binds 
to the hydrophobic pocket at the adenosine part of NAD, but not 
to the zinc binding moiety (Einarsson et al., 1974) in LADH. 
Salicylate is also an NAD-competitive inhibitor of DmADH. The 
Ki value of salicylate for DmADH is almost identical to that 
for LADH (Dawkins, 1967), suggesting a similar adenosine 
binding pocket.
1. 3 Functional Properties of DmADH
1.3.1 Major Functional Diffaranoas between DmADH and
Othar ADHa
DmADH shows not only little homology in primary sequence 
but also many functional differences when compared to the 
corresponding enzymes obtained from mammals, maize, and yeast. 
In addition to the differences in substrate preference as 
discussed in Section 1.2.4, DmADH requires no metal cofactors 
(Chambers, 1984), and stereochemically shows 4-pro-S hydride 
transfer (Benner et al., 1985). Horse liver and yeast ADH, in 
contrast, are more specific for primary alcohols (Dalziel & 
Dickinson, 1966), require zinc ions as cofactors (Dunn & 
Hutchinson, 1973), and show the 4-pro-R stereospecificity (You, 
1982) .
1.3.2 Reaction Mechanism of DmADH
The Theorell-Chance mechanism (Theorell & Chance, 1951) 
has been suggested for DmADH when secondary alcohols are used 
as the substrate (Winberg et al., 1982a). According to this 
mechanism, ternary complexes are not kinetically significant 
and the dissociation of enzyme-NADH complex is the rate- 
limiting step. Several lines of evidence have supported this 
mechanism: (i) for many of the secondary alcohols tested, Vm is
essentially the same (Winberg et al., 1982a); (ii) deuterated 
secondary alcohols do not give primary kinetic isotope effects 
(Heinstra et al., 1988) ,* and (iii) product inhibition displays 
the Theorell-Chance reaction feature (Heinstra et al., 1988).
With primary alcohols, in contrast of the above, the Vm 
of DmADH increases from ethanol to n-butanol, then decreases 
from n-butanol to n-octanol. The Vm for primary alcohols are 
much lower than those of corresponding secondary alcohol 
following Theorell-Chance mechanism. A primary kinetic isotope 
effect of around 3 occurred with deuterated ethanol. 
Furthermore, no product inhibition appeared at high ethanol 
concentration. This indicates that with primary alcohols, 
ternary-complex interconversion, i.e. hydride transfer, becomes 
the rate-limiting step. Winberg et al. (1982a) suggested that 
with primary alcohols, DmADH behaves similar to a carboxymethyl 
LADH (Reynolds et al., 1975), in which the rate-limiting step 
is the interconversion of the ternary complex. However, LADH 
normally follows the Theorell-Chance mechanism for primary 
alcohols with the dissociation of enzyme-NADH complex as the 
rate-limiting step.
1.3.3 Kinetic Constants and Thermal Stability of
DmADH
DmADH is not an allosteric enzyme. It obeys typical 
Michaelis-Menten kinetics. Table 4 lists the Km and specific 
activity relative to ADH-S for several DmADH variants.
Km* s for ADH-F and ADH-uF are more or less the same and 
both are higher than that of ADH-S and ADH-71K (Table 4), but 
the rank order of catalytic activity is ADH-uF > ADH-F > ADH- 
71K > ADH-S. It has been reported that ADH-71K does not show 
hydride transfer as the rate-limiting step for primary alcohol
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catalysis (Heinstra et al., 1988). As discussed in Section 
1.2.1, the difference of amino acid sequence between the ADH-S 
and ADH-F allozymes of DmADH is in the amino acid at position 
192 (Thatcher, 1980); between ADH-71K and ADH-F, in amino acid 
at position 214 (Heinstra, 1987 and Heinstra et. al., 1988); 
between ADH-uF and ADH-F, differences are found at both 
position 8 and 45. Thus, replacements in N- or C- terminal 
regions seem to influence enzyme function in an unpredictable 
manner. Viewing the DmADH null data (Section 1.2.1) with 
respect to these facts suggests that the entire tertiary 
structure of DmADH is involved in binding substrate and 
coenzyme (Hovik et al., 1984).
On the other hand, the rank order of thermal stability of 
the above allozymes is ADH-71K > ADH-F > ADH-S > ADH-uF 
(Chambers et al., 1984), supporting the premise that a single 
amino acid substitution may cause structural variation in 
DmADH.
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Tabla 4.
Km and Relative Spaelflc Activity for DmADH Isoaymea
Enzyme
Ethanol
*Km
(mM)
2-propanol
"Specific Activity 
(relative to ADH-S)
Ethanol 2-propanol
ADH-S 3.70 0.56 1.0 1.0
ADH-71K 4.5 N.A. 1.4 1.5
ADH-F 6.54 1.08 2.4 3.8
ADH-UF 5.5 1.2 7.5 4.5
• Km values are measured in pH 8.5-9.5 at room temperature 
and referenced from Winberg et al., 1982, 1988b;
Chambers, 1984; Heinstra et al., 1988. 
b Data are from Chambers et al., 1984.
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1. 4 8it«-dlr«et*d Huttgamais mod Protaln Inqlnwrl nq
Reviewing the past two decades of DmADH studies, it can 
be seen that neither natural variants nor randomly induced 
mutants have provided sufficient information to determine the 
structure-function properties of this enzyme. In order to 
further study these important properties for DmADH, individual 
amino acid residues must be examined for their structural and 
functional roles. Therefore, site-directed mutagenesis becomes 
a very powerful tool to achieve this goal.
The fundamentals of site-directed mutagenesis were 
developed in the early 1970s {Hutchinson & Edgell, 1971), but 
it was not until the late 1970s that the maturation in the 
techniques of oligonucleotide synthesis led to wide-spread 
application of site-directed mutagenesis for producing single 
or multiple base substitutions, insertions and deletions. The 
methodologies and applications of this technology have been 
reviewed (Smith, 1985; Craik 1985; Carter, et al., 1985;
Carter, 1986; Leatherbarrow & Fersht, 1986) .
Classically, site-directed mutagenesis involves t±J 
annealing a mutagenic oligonucleotide primer to a single­
stranded DNA template, [ii] in vitro synthesizing the second 
strand from the synthetic primer by in vitro DNA polymerization 
and ligation, and [iii] transforming the produced double 
stranded DNA into a bacterial host. More recently, polymerase 
chain reaction (PCR) (Higuchi et al., 1988) has been used to 
generate predetermined mutations. The advantage of this 
technique is that either double-stranded or single-stranded DNA
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template can be used, and mutations can be created in vitro 
without transformation. Both techniques have been used in this 
dissertation.
A key problem in site-directed mutagenesis is the low 
mutation rates. A common strategy to enhancement the frequency 
of mutations is to create an asymmetry between the two DNA 
strands by means such as hemimethylated DNA (Kramer et ai., 
1982; Marmenout et al., 1984), nonsense codons (Kramer et al., 
1984), the EcoK/EcoB system (Carter et al., 1985), lf- 
phosphorothionate dNTP analogues (Taylor et al., 1985a,b), and 
uracil containing DNA strand (Kunkel, 1985; and Kunkel et al., 
1987). The mutation can be enriched by either physical 
separation or genetic selection.
Kunkel's procedure (1985) for mutation enhancement is 
used in this dissertation. Briefly, a single stranded uracil- 
containing Ml3 template is prepared in a dUTPase and uracil N- 
glycosylase defective E. coli strain. The second strand, 
synthesized in vitro from a mutagenic primer, does not contain 
uridine. Transformation of the heteroduplex into an E. coll 
strain wild-type in dUTPase and uracil N-glycosylase results in 
excision of uridine so that the strand which carries the 
mutation is preferentially enriched.
Site-directed mutagenesis was first applied to study 
protein function to tyrosyl-tRNA synthetase (Winter et al., 
1982), ^-lactamase (Dalbaldie-McFarland et al., 1982; Sigal et 
al., 1982; and Charles et al., 1982) and prolipoprotein (Inouye 
et al., 1982). In recent years, protein engineering has been
22
widely applied to alter the thermal stability of a protein 
(Nicholson, et al., 1988; and Kellis Jr, et al., 1988); change 
substrate-specificity (Hells et al., 1987; and Bone et al., 
1989); and study peptide folding pathways (Oas & Kim, 1988).
The most common application of protein engineering by site- 
directed mutagenesis is for studying the catalytic and 
regulatory mechanisms of enzymes; specifically, how an 
individual amino acid residue contributes to enzymatic 
function. For example, in serine proteases, three key amino 
acid residues (a catalytic triad) have been mutated 
systematically to determine their function (Craik et al., 1987; 
Sprang et al., 1987). Fructose 6-phosphate-l-kinase (PFK), an 
allosteric enzyme, has been mutated at its regulatory sites to 
investigate the conversion between tight and relaxed 
conformation as well as regulation by individual ligand (Valdez 
et al., 1989). It is, therefore, possible to elucidate the 
structure-function relationship of a enzyme by protein 
engineering and site-directed mutagenesis.
1.5 Rationale and ObjectIves
The physical and biological properties of a protein 
molecule are determined by its structure. In nature, proteins 
with related functions usually show common structural features. 
The enzymes in the serine or cysteine protease families, for 
instance, have three common residues (a catalytic triad) in 
their active site (Fersht, 1985). Some DNA binding proteins
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contain zinc fingers or leucine-zippers for dimerization (Klug 
& Rhodes, 1987; and Landschulz et al., 1988).
DmADH is unique among alcohol dehydrogenases in its metal 
ion requirement, substrate preference, and stereospecificity of 
hydride transfer. However, the structure-function relationship 
has not been elucidated. There are two basic questions 
remaining on DmADH studies.
First, how closely related, structurally, is DmADH to 
other alcohol dehydrogenases? NAD-dependent dehydrogenase have 
been shown to have a common NAD binding domain of six parallel 
^-sheets connected by e(-helixes (Rossman et al., 1975; 1983). 
Although DmADH has no overall sequence homology with LADH or 
other ADHs, a predicted secondary structure reveals a similar 
NAD binding domain and several highly conserved residues 
(Benyajati et al., 1961). On the basis of this speculated 
secondary structure, experiments were designed to investigate 
the function of this predicted NAD-binding domain. Results 
from this study support the notion that common structural 
features may play an important role in the coenzyme-binding of 
NAD-dependent dehydrogenases, including DmADH.
The second question concerns the catalytic mechanism of 
this unique ADH. It has been shown that the substrate binding 
site of DmADH is adjectively different from that of LADH, and 
that there is no zinc ion involved in the catalytic reaction 
(Section 1.2.4 6 1.3.1). LADH has several cysteine residues 
which serve to hold the zinc required for the catalytic 
activity. But, DmADH has only two cysteines and, more
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importantly, no zinc ion. One of the cysteines shows 
sensitivity to chemical modification with an accompanying loss 
of ADH activity. The function and position of these two 
cysteines in the catalytic fold are unclear. Clarification of 
earlier ambiguous observations would help locate the active 
site and, further, deduce the reaction mechanism of DmADH which 
might be different from that of LADH.
DmADH has a small coding gene with two short introns. It 
has been cloned into the M13mpl8 vector in our lab. By using 
site-directed mutagenesis, it is possible to manipulate this 
gene for its expression in E. coll host and to change certain 
key amino acids for the structure-functional investigation of 
DmADH.
The specific aims of this study are the following:
1. To construct a DmADH cDNA and establish a high 
expression system for DmADH.
2. To test the structural role of glycine-14 in a 
putative NAD-binding site of DmADH; therefore, to prove a 
common NAD-binding domain for DmADH with other ADHs.
3. To test the function of the two cysteine residues in 
DmADH and to locate the active site of this enzyme.
CHAPTER TWO 
MATERIALS AMD ISTH0D8
2.1 Materials
2.1.1 Ensymes and Antibody
All restriction endonucleases, DNA ligase, DNA kinase, 
mung bean nuclease, T4 DNA polymerase, and Klenow DNA 
polymerase were purchased from Bethesda Research Laboratories 
(BRL) (Bethesda, MD), New England Biolabs, Inc. (NEB) (Beverly, 
MA), Promega Biotec Corporation (Madison, HI), Boehringer- 
Mannheim Biochemicals (Indianapolis, IN), and Pharmacia 
(Piscataway, NJ). Nick translation kits and ligation kits were 
ordered from BRL. Sequenase kits were obtained from United 
States Biochemicals Corp. (USB) (Cleveland, OH). Tag DNA 
polymerase kits which were used for polymerase chain reaction 
(PCR) were from Perkin Elmer Cetus (Norwalk, CT). Pancreatic 
ribonuclease and deoxyribonuclease were bought from Sigma 
Chemical Co. (Sigma) (St. Louis, MO). Alcohol dehydrogenase 
isolated from Drosophila melanogaster and rabbit antibodies 
against the fly protein were prepared by Batzer et al. (1988).
2.1.2 Chemicals
Bacto-tryptone, bacto-yeast, and bacto-agar were products 
of Difco Laboratories (Detroit, MI). Agarose, dithiothreitol, 
urea and phenol were purchased from BRL or American Research 
Products Company (AMRESCO) (Solon, OH). Low melting point 
SeaPlaque was obtained from FMC Corporation (Rockland, ME).
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SeaPlaque was obtained from FMC Corporation (Rockland, ME). 
Acrylamide, N,N'-methylene-bisacrylamide, TEMED, and ammonium 
persulfate were ordered from BIO-RAD (Richmond, CA) or AMRESCO. 
Acrylamide stock solution (40 %, w/v) (ACRYL-40) and N,N'- 
methylene-bis-acrylamide stock solution (2 %, w/v) (BIS-2) were 
obtained from AMRESCO. 5-bromo-4-cloro-3-indolyl-9-D- 
galactoside (X-gal) was ordered from United State Biochemical 
Co. (Cleveland, OH). Isopropyl-B~D-thiogalactopyranoside 
(IPTG), 2(morpholino)ethanesulfonic acid (MES), Tris- 
(hydroxymethyl)aminomethane (Tris), hexamine cobalt chloride, 
polyvinylpyrrolidone (PVP), thylenediaminetetra-acetic acid 
(EDTA), tetramethylammonium chloride, sodium dodecyl sulfate 
(SDS), polyethyleneglycol (PEG), nicotinamide adenine 
dinucleotide (HAD), nicotinamide adenine dinucleotide phosphate 
(NADP), uridine, 5,5'-dithiobis(2-nitrobenzoate) (DTNB), 
phenylmethylsulfonyl fluoride (PMSF), Cibacron Blue 3GA-Agarose 
(Type 3000-CL-L), Sephadex G-100, ampicillin, kanamycin, 3-(N- 
Morpholino)-propanesulfonic acid (MOPS), 5-bromo-4-chloro-3- 
indolyl phosphate (BCIP), and nitro blue tetrazolium (NBT) were 
purchased from Sigma. Rubidium chloride was ordered from 
Morton Thiokol. Inc. (Danvers, MA). Premade Sephadex G-50 
(Select-D) columns were from 5 Prime - 3 Prime, Inc. (Paoli,
PA). Nitrocellulose filters were ordered from Schleicher and 
Schuell (Keene, NH). Films (XAR-5 and XRP-5) were from Eastman 
Kodak Co. (Rochester, NY). Polaroid films were purchased from 
Polaroid Co. (Cambridge, MA).
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2.1.3 Radio-isotop* Labelled nucleotides and 
Oligonucleotides
Deoxynucleoside triphosphates labeled at the alpha 
position and ribonucleoside triphosphates labeled at the gamma 
position with **P as well as [c(-“S] dATP were products of ICN 
Biomedicals, Inc. {Irvine, CA) and New England Nuclear (NEN)/Du 
Pont Co. (Wilmington, DE). Oligonucleotides were synthesized 
by solid support method (Matteucci & Caruthers, 1981) in an 
automated DNA synthesizer (Applied Biosystems, Model 380A) and 
purified according to the catalog for "Oligonucleotide 
Purification Cartridges" and the protocal from Khorana 
(personal communication) (Appendix IV). The synthetic 
oligonucleotides used in this work, are listed in Appendix III.
2.1.4 Bacterial Strains and Vectors
The bacterial strains used in this work as well as their 
genotypes and references are listed in Table 5.
Plasmid containing Drosophila melanogaster adh (psACl) 
was a gift from Sofer. The expression vector with the lambda 
PL promoter (pPL2) and the plasmid with a cI857ts gene (pCI857) 
were gifts from Khorana. M13mpl8 and M13mpl9 were ordered from 
BRL.
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Table 5. 
Baotarlal Strains
E. COll 
Strain
Genotype Reference
BW313 HfrKL16 PO/45tiysA(61-61)], dutl, ungl, 
thll, relAl.
Kunkel,
1985
CSH50 [A(pro-iac)], ara, thl, strA/F*, (traD36r 
proAB, lacX^ Z" M15) .
Kunkel
1985
JM110 (pro-lac), dam, dcm, rpsL, thr, leu, 
thl, lacY, galK, galT, ara tonA, tax, 
svpE44, (F', traD3€, proAB, lacIqZ~ M15)
Yanisch- 
Perron, 
et al., 
1985
DH5«F' F', endAl, hsd El 7, supE44, thl, recAl, 
gryA96, relAl, A ‘, SOdlacZ Ml5,
(1acZYAargF)U169
BRL
Cat. No. 
8264SA
M5219 N*, F~lacZ, trp, Snf, gal3, chi, bio, 
uvrB, (AN7N53CI857H1)
Patrick, 
et al., 
1981
LC137 htpEIts, Ion"*' lac, trp, pho, rpsL, 
supC", mal, tsx: :TnlO
Goff et 
al. 1984
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2.2 Method*
The details of experimental procedure and common reagents 
used in the following methods are described in Appendices IV 
and V.
2.2.1 Construct ion of the full-length Adh cDMA by
Site-directed Deletion* - Kunkel'* Method
In order to express Drosophila melanogaster alcohol 
dehydrogenase <DmADH) in E. coll, it was necessary to construct 
a DmADH cDNA. As mentioned in Chapter One, the DmADH coding 
region contains two small introns (65 bp and 70 bp). Deletion 
of the two introns in DmADH by Kunkel's method of site-directed 
mutagenesis (1985) (Appendix IV) is an efficient way to achieve 
the purpose. A 3.2 kilobase Xbal fragment containing DmAdh was 
excised from psACl and subcloned in M13mpl8. Single-stranded 
M13/Adh containing uracil was prepared in an E. coll host 
defective in dUTPase and uracil glycosylase (BW313) as 
described by Kunkel (1985). This single-stranded template was 
hybridized with synthetic primer (INTRON1 or INTRON2) 
containing the base sequence corresponding to seven codons in 
the carboxyl end of one exon and seven codons in the amino 
terminus of the adjacent downstream exon (Fig. 4). The 
complementary strand lacking uracil was synthesized in vitro 
along the M13/Adh template using DNA polymerase I (Klenow) in 
the presence of all four deoxynucleoside triphosphates.
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Transformation of a dut*, ung* E. coll host (CSH50) with this 
heteroduplex DNA selects against the uracil-containing strand, 
so that progeny phage should contain predominantly DmAdh 
without introns. This prediction was confirmed by DNA sequence 
analysis.
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Exon 1 Exon 2 Exon 3 Exon 4
TAA M13
O ^
fMMa BagiM /li i BKMMillHM I — —
M13mp18 DNA c a r r y i n g  c==j Jf
D.m.  ADH gene Synthet ic pr imers co m plem enta ry
DNA prep ar ed  in d u f u n g '  to the  t e rmina l  s e q u e n c e  of
d u — du
E. coli cells. a d j a c e n t  exons
dATR dCTP,  d T T P ,  dGTP 
Klenow
vs//////,
I
I
+* +
Trans fec t ion  in dut ,ung cel ls
Rep l ica t ion
M 1 3 m p 1 8  DNA ca r ry ing  full  l e n g t h  
D. m e l o n o g a s t e r  ADH cDNA
Fig. 4 Construction of DmADH cDNA by Xunkol's method. The
method is described in Section 2.2.1 and Appendix 
Four. The uracil containing template was hybridized 
with synthetic mutagenic primers. After a 
complementary strand was synthesized in vitro, the 
double strand Ml3 was transformed into E. coli 
CSH50.
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2.2.2 Subcloning and Ispraaaion of DwJtdth cDMA
An M5219/pPL2 system is used for DmAdh expression. The 
expression vector pPL2 contains a lambda PL promotor which is 
highly efficient for transcription and can be controlled by 
lambda repressor (lambda cl gene product). E. coli strain 
M5219 carries a defective prophage with cl857 thermo-sensitive 
mutation, thus providing a convenient control for lambda PL 
promotor.
Subcloning of Adh cDNA into pPL2 is shown in Figure 5.
One modification to Ml3/Adh cDNA was made in order to 
facilitate the subcloning. An BcoRI site was introduced by 
Kunkel's method of site-directed mutagenesis immediately 
upstream of the ATG start codon. Since there is a unique Ball 
site 244 bp downstream from the TAA termination codon, the new 
BcoRI site enabled us to excise the entire DmADH coding 
sequence. After mung bean nuclease digestion which creates a 
blunt end from the cohesive termini produced by BcoRI 
digestion, the Adh cDNA was inserted into pPL2 at 12 bp 
downstream from the Shine-Dalgarno sequence (Guarente et al, 
1980). This construct preserves the correct translation 
reading frame.
pPL2 was digested with HindiII and SacI and purified by 
gel electroelution. The 5'-protruding terminus generated by 
Hindlll was filled by the polymerase activity of T4 DMA 
polymerase in the presence of all four deoxynucleoside 
triphosphates. The 3' overhang of the Sad site was removed by 
the 3' to 5' exonuclease activity of the same enzyme. The
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vector and Adh cDNA were joined by T4 DNA ligase. This plasmid 
construct (pPL/Adh) codes for wild-type ADH.
To produce point mutation, a wild-type Adh cDNA was 
excised from pPL2/Adh with Clal and EcoRI. The Adh insert 
fragment was cloned into M13mpl9 and digested with EcoRI and 
AccI. The AccI site then was mutated to Clal, making the Adh 
insert fragment easy to subclone back and forth between pPL2 
and Ml3 vectors.
E. coll M5219 was transformed with pPL2/Adh. Colonies 
grown in the presence of ampicillin were screened for Adh by 
colony hybridization (Maniatis et al., 1982). Liquid cultures 
of positive colonies were grown to mid-log phase at 28°C, heat 
shocked at 42“C for 30 min, and incubated at 37°C for three 
hours. Cells from the cultures were harvested and sonicated. 
DmADH was identified by an enzyme activity assay (Lee, 1982) 
(Appendix IV) and sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The results of SDS-PAGE were 
analyzed by densitometer scanning (Bio-Rad, Model VD-620).
In order to express protease-sensitive mutants of DmADH, 
protease defective E. coll LC137 was co-transformed with the 
pPL2/Adh and plasmid pCI857. Colonies were grown in the 
presence of ampicillin and kanamycin. Liquid cultures of 
transformants were grown to mid-log phase at 30°C, heat shocked 
at 42°C for 15 min, and incubated at 37°C for 4 hours.
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Modified ADH c DNA
E c o R l Bal I
ATG TAA 1or
EcoRI 
Bal I
Mung Bean  Nuc lease
T 4  DNA Pol  
4  d NTP DNA L i go s e
C l a l
Adh
Or i
A p
T r a n s f o r m a t i o n  of  E . coli M 5 2 1 9  
2 8 ° C  unt i l  m i d  log p h a s e  
4 2 °  C , 3 0  min  ; 3 7 ° C  , 3 h r  
Harves t  c e l l s  
Pur i fy  D ro s op h i l a  ADH
Fig. 5 Subcloning of DmADH cDNA into pFL2. The
experimental procedures have t^ een described in 
Section 2.2.2. Adh cDNA digested by EcoRI and Ball 
was subcloned at the f/indlll and SacI sites by blunt 
end ligation. The recombinant plasmid was used to 
transform E. coli strain M5219. Adh cDNA was then 
excised from pPL2/Adh with Clal and EcoRI and cloned 
into M13mpl9 for further purposes.
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2.2.3 Purification of DaADH front X. coli
Large scale cultures of transformed cells at late log- 
phase were pelleted at 4°C, 7,000 x g for 30 min and 
resuspended at 10% by weight in sonication buffer (Appendix V). 
Cell suspensions were sonicated for 5 min on ice (Heat Systems, 
Model W-225R), and cell debris was removed by centrifugation at
23,000 x g. The supernatant was adjusted to 40% ammonium 
sulfate saturation and centrifuged to remove precipitated 
proteins. Ammonium sulfate concentration was increased to 60% 
saturation; the resultant protein precipitate was dissolved in 
column buffer (Appendix V) and applied to a Sephadex G-100 
column (2.5 x 120 cm). Eluted fractions containing the 
majority of ADH activity were pooled and applied to a Cibacron 
Blue 3GA-Agarose column (2.5 x 20 cm) equilibrated with the 
same column buffer. Proteins were eluted by a NaCl gradient (0 
to 2 M). DmADH was eluted at approximately 1.5 M NaCl, 
concentrated in an Amicon ultrafiltration cell, and stored at 
-20°C. Aliquots from each step of purification were analyzed 
for protein concentration and ADH activity.
2.2.4 Creating Point Mutations in DmADH
Five mutations were created in these studies: GA14 (Gly- 
14 to Ala), GV14 (Gly-14 to Val), CA135 (Cys-135 to Ala), CA218 
(Cys-218 to Ala), and CA135/CA218 (Ala substitutions at both 
Cys-135 and Cys-218). Mutagenesis for the first three was 
carried out by Kunkel's method (Appendix IV).
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Several attempts to construct the CA218 mutant using 
Kunkel's method were unsuccessful. He then used polymerase 
chain reaction (PCR) (Higuchi et al., 1986) (Appendix IV) to 
generate the CA218 mutation. Four synthetic primers were 
prepared to produce a 655 bp partial DmADH cDNA fragment which 
has Cys to Ala mutation at position 218, a BamHI site at the 5' 
end and an BcoRl site at 3' end (Fig. 6). A218A and A218B are 
mismatched primers to make the mutation at position 218; BAMA 
and ECOB are the primers containing respectively BamHI and 
BcoRI linkers. The first step in this method was to make a 270 
bp DNA fragment primed by A218A and BAMA, and a 416 bp DNA 
fragment primed by A218B and ECOB using PCR conditions 
described by Higuchi et al.(1988) and the protocol for "GeneAmp 
DNA Amplification Reagent Kit (Perkin-Elmer Cetus) (Appendix 
IV). These two fragments are complementary for 31 bp centered 
at the locus of CA218 mutation. A mixture of 0.3 pmole of each 
fragment produced from the step one was extended for 20 cycles 
of PCR in the presence of 50 pmole each of BAMA and ECOB. The 
655 bp DNA fragment produced was linked to pPL2 vector 
containing wild-type DmADH cDNA at the BamHI and EcoRI sites by 
DNA ligase. This procedure constructed a pPL2 derivative 
containing the CA218 mutation. To generate the CA135/CA218 
double mutant, the 655 bp PCR fragment was inserted in the same 
EcoRI and BamHI sites of the CA135 cDNA.
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Fig. 6
Bom MI
BAMA 
■ »
EcoRI
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A. Diagram of partial Drosophllm ADH cDNA and tba 
primers used for PCR. Total length of this region 
is 655 bp. B. Agarose gal electrophoresis
showing the three fragments generated by PCR.
38
2.2.5 Western Blot of Daws
Identification of cloned proteins on SDS-PAGE using an 
antibody against DmADH was described in Batzer et al., (1988) 
(Appendix IV). Samples for SDS-PAGE were prepared from crude 
extracts of E. coll M5219 transformed with the expression 
vector pPL2 containing or lacking Adh cDNA.
2.2.6 Determination of Kinetic Parameters and 
Inhibition Studios
ADH activity was determined spectrophotometrically at 340 
nm in the presence of two substrates, alcohol (2-propanol or 
ethanol) and NAD, in 100 mM Tris-Cl buffer (pH 8.7 or 
specialized) at 25°C. Figure 7 shows the time course of 
absorbance at 340 nm recorded by a spectrophotometer (Gilford- 
Response). The initial velocity (absorbance changes per min) 
can be calculated by the spectrophotometer. All Km and Vmax 
values were calculated from duplicate initial velocities 
determined at five substrate concentrations. Ki values were 
calculated from Km values determined as above at increasing 
concentration of the inhibitor (pyrazole: 0 pM, 5 pM, 10 pM; 
NADP: 0 pM, 100 pM and 500 pM). Km and Vmax were calculated by 
ENZFITTER program (Elsevier-BIOSOFT) on a personal computer. 
Reactions were initiated by adding ADH. Concentrations of NAD 
and alcohol were specified as follow: the KmupptNAD was 
determined for NAD between 0.1 and 1 mM with a constant alcohol 
concentration of 10 mM, and the KmiapptAic for alcohol at 
concentrations from 2 to 10 mM with a constant NAD
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concentration of 1 mM. The Ki for pyrazole was assayed by 
varying the ethanol concentration from 2 mM to 10 mM at a 
constant MAD concentration, while the Ki for NADP was measured 
by varying NAD concentration from 0.1 mM to 1 mM at a constant 
alcohol concentration.
2.2.7 Thermal Denaturat ion Study
Crude extracts of E. coli LC137 containing wild-type or 
mutant Adh cDNA were incubated at 40°C for 60 min. Aliquots of 
100 pi from each sample were taken every 6 min and assayed for 
ADH activity (Lee, 1982) (Appendix IV). All assays were 
performed in duplicate.
2.2.8 DTHB Modification of Wild-type and Mutated 
DnADH
DTNB can react with the ionized cysteinyl residue to 
produce 5-thio(2-nitrobenzoate) (TNB) which showsAmax at 412 
nm (Riddles, et al., 1979).
DmADH (10 pM) was mixed with DTNB (100 pM) in 1 ml of 0.2 
M Tris-Cl buffer (pH 8.0) at 25°C in the presence or absence of 
1 mM NAD and 10 mM 2-propanol. The absorbance at 412 nm was 
recorded at 0.25 min intervals on a spectrophotometer (Gilford- 
Response II).
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2.2.9 DTKB Inactivation of Wild-typo and Mutatad
DaJUDB
DmADM (4 pg) was incubated in 200 pi of 100 pM DTNB and 
0.2 M Tris-Cl buffer (pH 0.0) at 25°C for 10 min. Aliquots of 
20 pi from each sample were taken every 3 min and assayed for 
ADH activity in duplicate.
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Fig. 7 The tins course of absorbance at 340 nm. The
velocity of DmADH catalysis is defined as the 
absorbance changes per min.
CHAPTER THREE
EXPRESSION OP WILD-TYPE AMD MUTANTS DROSOPHILA ADH IN N. COILT
3.1 Construction u d  Expression of Dromophllm ADH cDHA
Sequencing results show that the two introns of DmADH 
were deleted and that all three exons were fused correctly, 
preserving in-frame translation (Fig. 8) and that unintentional 
mutations had not been introduced.
SDS-PAGE (Fig. 10) shows that transformation of E. coll 
M5219 with pPL2/Adh provides a high level of protein expression 
and that DmADH produced in E. coll is the same size as the 
authentic protein (27 KDa). SDS-PAGE also shows that Adh 
inserted in the wrong orintation reveals a different 
restriction pattern (Fig. 9) and does not produce ADH.
3.2 Purification of DnADH from E. ooli
The purification procedure has been described in Section 
2.2.3. It includes ammonium sulfate precipitation steps, a gel 
filtration column (Sephadex G-100), and an affinity column 
(Cibacron Blue 3GA-Agarose). The results of wild-type DmADH 
purification are shown in Figure 11 and Table 6.
A maximum of 17-fold purification was achieved during the 
purification of wild-type DmADH from E.coll M5219. Based on 
SDS-PAGE, the DmADH has been purified to homogeneity. The 
limited purification is a result of the high expression of 
DmADH in the E. coll host.
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Asn L e u
Intron I AACCTG
Intron lese  C 
Mutation (I) O
CTGAAG (AACCTG 
Lou Lys Asn Leu
Lys Leu 
Intron fl -*|AAA CTG
Intron less  C 
Mutation (II) Q
CTGGCG|AAACTG
Leu Ala Lys Leu
F i g .  8 DMA leqaeno* showing ths two introns ha vs been
deletsd. The deletion was carried out by Kunkel's 
method (1985) (Section 2.2.1 and Appendix IV). 
Sequencing was performed by dideoxy chain 
termination method as described in Appendix IV.
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EcoRI
Fig. 9 Southern blot showing ths rsstrlctlon pattarn of Adh 
inserted In pPl*2 oppression vector.
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21 .000
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14,400
Fig. 10 SDS-PAGE showing that pPX*2/Adh products ADH p rot sin.
Samples were prepared from crude extract of E. coll 
M5219. Lane 1: M5219; Lane 2: M5219/pPL2; Lane 3: 
M5219/pPL2/Adh (the Adh clone showing a wrong 
restriction pattern which is clone 3 in Fig. 9);
Lane 4: M5219/pPL2/Adh without heat shock; Lane 5: 
M5219/pPL2/Adh with heat shock; Lane 6: DmADH 
isolated from the fly; M « Size Marker (Bio-Rad).
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Fig. 11 SDS-PAOB showing tba purification of DmADH wild-typ* 
from X. coll M5219. Lane 1: crude extract; Lane 2: 
after ammonium sulfate precipitation; Lane 3: after 
Sephadex 6-100 column; and Lane 4: after Cibacron 
Blue column; Lane 5: M - Size Marker (Bio-Rad) .
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Tabla 6.
Purification of DaADH from M. aoli Boat
Step Volume 
ml
Protein
mg
Total 
Activity 
10“ U*
Specific Fold of 
Activity 
10“ U*/mg Purification
Crude
Extract 50 688 3.6 0.52 1
Ammonium
Sulfate 2 142 1.2 0.85 1.6
G-100
Sephadex 4 40.2 1.1 2.7 5.2
Cibacron
Blue 3 6.0 0.54 9.0 17
One unit of activity is defined as a change in absorbance at 
340 nm of 0.001 per min (Sofer & Ursprung, I960).
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3. 3 Mutations and Thalr Expression
In order to study the structure and function of DmADH, 
the following point mutations were introduced by Kunkel's and 
PCR methods: GA14 [Gly-14 (GGT) to Ala (GCT)], GV14 [Gly-14 to 
Val (GTT)], CA135 [Cys-135 (TGC) to Ala (GCC)], and CA218 [Cys- 
218 (TGC) to Ala (GCT)]. Figs. 12 and 13 are the sequencing 
results for these mutations.
There were no difficulties in expressing CA135 and CA218 
in E. coli M5219. However, expression of GV14 is less than 10% 
of wild-type and GA14 expression is 70% of wild-type. Western 
blot analysis (Fig. 14) shows that E. coli M5219 produces ADH 
when transformed with either pPL2/Adh wild-type cDNA or mutant 
cDNA.
Expression of GV14 can be improved significantly in a 
protease defective host (LC137) (Goff et al., 1984). Crude 
extracts of LC137 transformed by pPL2/Adh wild-type, GA14, and 
GV14 cDNAs were separated by SDS-PAGE (Fig. 15) and analyzed by 
densitometer scanning. The results show that GV14 protein 
expression is 66% of wild-type. However, the specific activity 
of ADH in the crude extracts of GV14 transformed E. coli LC137 
is less than one percent of wild type.
Fig. 12 DINA saquanca showing the mutation of Gly-14 to Ala 
(GA14) and Val (GV14) In DmADH gena. The
mutagenesis was performed by Kunkel's method <1985) 
(Section 2.2.4 and Appendix IV). Sequencing was 
carried out by dideoxy chain termination method as 
described under the Appendix IV.
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T 0 C A T O C A
CA218
Fig. 13 DMA stqutnot showing th« natation of Cys-135 to Ala 
(CA135) and Cya-218 to Ala <CA218) In DaKDB. The
mutagenesis was carried out by both Kunkel's method 
<1985) and PCR (Higuchi et al., 1988) (Section 2.2.4 
and Appendix IV). Sequencing was performed as the 
same as in Fig. 12.
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Fig. 14 Western blot of wild-typo and mutated DmADH 
protolna. Crude extracts of E. coll M5219 
transformed by the Adh cDNA plasmids were analyzed 
directly on SDS-PAGE. Immunochemical Identification 
of cloned DmADH on SDS-PAGE was described In Batzer 
et al. (1968). Lane 1: pPL2, no Adh Insert; lane 2: 
pPL2/GA14; lane 3: pPL2/GV14; Lane 4: purified wild- 
type DmADH.
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•7,400 
•4,*00
«*,•••
•1,000
si.soo
14,400
Fig. 15 8D8-PASB showing tho expression of DnADH wild-typo
and nutants In K.coll LC137. The samples were 
prepared directly from crude extracts of E.coli 
cells. Lane 1: LC137/pPL2/Adh; Lane 2: LC137/GA14; 
Lane 3: LC137/GV14; Lane 4: purified DmADH; M - Size 
Marker (Bio-Rad). Protein bands were visualized by 
Coomassie-blue staining (Bio-Rad).
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3.4 Discussion
Site-directed intron deletion offers alternative way to 
construct cDNAs for eukaryotic genes. The traditional 
procedure for synthesis cDNA is by reverse-transcription.
There are two major disadvantages to this method. First, the 
abundance of mRNA for single copy genes are usually low; 
secondly, reverse transcription terminates prematurely at a 
high frequency; thus, it is not easy to obtain a full length 
cDNAs from reverse transcription. Site-directed intron 
deletion, in contrast, is not suffered from these limitations. 
This method is suitable for a short gene with small numbers of 
intron. Introns up to 309 bp in length have been deleted by 
this method (Larson et al., 1983). However, if there are large 
numbers of introns, it will be tedious to produce cDNA by site- 
directed intron deletion. It would also be impractical to 
delete introns which are several Kbp in length.
We achieved an overall 30% or greater mutation efficiency 
using the method developed by Kunkel (1985) and 14% by PCR 
(Higuchi et al., 1988). In most cases, Kunkel's method is an 
efficient way to generate mutations. However, this method 
occasionally is unsuccessful as described in Section 2,2.4. It 
has been noticed that the mismatch repair system of B. coll can 
correct preferentially the newly made strand of heteroduplex 
(Leatherbarrow & Fersht, 1986). PCR has an advantage over 
Kunkel's method at this matter, since the mutagenesis is 
completed in vitro. However, DNA synthesis is carried out at 
high temperature (about 70°C) by Tag DNA polymerase in PCR so
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that a high frequency of unexpected mutations becomes a major 
disadvantage in PCR methods.
Lower expression of GV14 in M5219 is not the result of 
codon preference by E. coll since expression can be increased 
by use of LC137, a protease deficient host. The difficulty 
observed in expressing GV14 in M5219 may be the result of 
protease sensitivity induced by structural changes in the 
mutated protein.
CHAPTER POOR 
USING SITE-DIRECTED MUTAGENESIS TO INVESTIGATE 
THE STRUCTURAL FUNCTION OF GLY-14 IN DmADH
As discussed in the "Introduction" (Section 1.2.2), 
glycine-14 in DmADH is the first residue of a "conserved 
sequence" (GlyXGlyX,Gly) in an putative NAD binding site of 
DmADH (Benyajati et al., 1981). It may be critical for 
maintaining the tight turn structure required for correct 
conformation of the NAD binding domain. In order to determine 
the exact function of Gly-14, we created Gly-14 to Ala (GA14) 
and Gly-14 to Val mutants (GV14) by site-directed mutagenesis 
to investigate systematically the effect of the side chain at 
position 14.
4 .1 Thermal Denaturation Studies
Chambers et al. (1984) showed that DmADH can be denatured
by heating at 40°C. We carried out thermal denaturation on 
wild-type as well as mutated DmADH. The results (Fig. 16) show 
that wild type loses 30% of its activity after one hour at 
40°C, whereas GA14 loses 90% of its original activity under 
identical conditions. Since the host strain, E. coll LC137, 
used for this experiment is deficient in proteases, it is 
unlikely that thermal inactivation of GA14 is caused by 
protease cleavage, although we can not completely rule out this 
possibility. Detection of thermal denaturation for GV14 is
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Fig. 16 Thermal denaturation of wild-typa and mutant DmADH.
Crude extracts (1 ml) of E. coll LC137 transformed 
with Adh DNA were incubated in sonication buffer, pH 
7.4, at 40°C for 60 min. Aliquots of 100 pi were 
assayed for ADH activity every 6 min (Lee, 1982). 
Relative ADH activity is expressed as a percentage 
of wild-type initial velocity without heat 
treatment. ■ WT; ^  GA14; and QGV14.
57
essentially impossible due to the extremely low specific 
activity of the mutated protein.
4.2 Kinetic Analysis of Wild-Type DndhDH and GA14
We found that the kinetic behavior and substrate 
specificity of cloned DmADH is essentially identical to that of 
ADH isolated from the fruit fly (Table 7). Comparisons between 
cloned wild-type DmADH and its mutants can be extrapolated, 
therefore, to ADH isolated from Drosophila. The valine 
substituted mutant has almost no ADH activity, while the 
alanine substituted mutant shows decreased activity (69% of 
wild-type). Replacing Gly-14 with alanine increases the Km for 
NAD approximately three fold with little effect on Km for 2- 
propanol. Further, the kcat/KmiappjtiAD is decreased five fold in 
GA14, while the keat/Km(app)Aic shows no significant differences 
between wild-type and mutant. These results strongly suggest 
that the mutation in GA14 affects the binding of NAD but not of 
2-propanol.
4.3 Inhibitton Studies
Pyrazole is a competitive inhibitor of ethanol (Winberg 
et al., 1982b). The inhibition constant for pyrazole is nearly 
identical in wild-type and GA14 (Table 8), suggesting that the 
alcohol binding domain is not affected by alanine substitution. 
On the other hand, we observed that NADP inhibits wild-type 
DmADH competitively while having almost no effect on GA14 
activity (Fig. 17). These results indicate that the structure
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of the NAD binding domain in GA14 has been changed such that 
NADP can no longer compete with NAD for binding to the active 
site.
59
Table 7.
ta(app) and ko«t Values for Cloned Wild-type and GA14*
ENZYME FORM Km(app) 
mM
keat
sec-1
kcat/Km (app) 
(sec)'1 (mM) ^
NAD 2-propanol NAD 2-propanol
Wild-type
(authentic)*1 0 . 19 0 . 69
Wild-type 
(recombinant) 0 . 12  ± 0 .02 0 . 61  ± 0 . 09 2 . 8  ± 0 . 02  23 . 3  4 . 6
GA14 0.42  ± 0 . 03 0 . 56  ± 0 .02 1 . 9  ± 0 . 01  4 . 5  3 . 4
* Enzyme were assayed as described under Section 2.2.6.
The KmtappiNAD was determined for NAD concentrations between 0.1 
and 1 mM with a constant alcohol concentration of 10 mM. The 
Km(app)Aic was measured for alcohol concentration from 2 to 10 mM 
with a constant NAD concentration of 1 mM.
“Data are from the reference (Chambers, 1984).
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Tablt. I 
Ki Valuta ot Pyruole and MADP*
Inhibitor Ki (pM)
Wild-type GA14
Pyrazole1* 3.49 ± 0.53 4.52 ± 0.02
NADP 716 ± 0.4 N. A.
“The inhibition constants <Ki) were obtained by ENZFITTER 
program as mentioned in Section 2.2.6. The Ki for pyrazole was 
assayed by varying the ethanol concentration, while the Ki for 
NADP was measured by varying the NAD concentration in 100 mM 
tris-Cl (pH 9.8).
“The literature value of Ki for pyrazole is 4.4 pM 
(Winberg et al., 1982).
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Fig. 17 Iffaet of NADP on wild-typo and mutated DmADH
activity. These experiments were performed in 100 
mM tris-Cl, pH 9.8, with a constant ethanol 
concentration of 10 mM at 25°C. Initial velocities 
were measured in the absence {X ); and presence of 
(□) 100 pM; and (Z*) 500 pM NADP. A: wild-type 
DmADH; B: GA14.
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4.4 Discussion
DmADH differs from horse liver ADH in metal ion 
requirement, substrate preference, and stereospecificity of 
hydride transfer. When compared to ADH from other species, 
DmADH has little sequence homology, but the predicted secondary 
structure in the NAD binding domain resembles remarkably that 
of horse liver ADH (Benyajati et al., 1981). Crystallographic 
studies of numerous NAD-dependent dehydrogenases reveal a 
common structure of six parallel 9 -sheets with five intervening 
o(-helices <Rossmann, 1983) . The first three 9-sheets and two 
ot-helices comprise the AMP binding unit (Rossmann et al.,
1975) . A "conserved sequence" of GlyXGlyXaGly is located at 
the sharp turn between the first ^ -sheet and * -helix in the 
nucleotide binding domain of many dehydrogenases (Argos & 
Leberman, 1985), kinases (Walker et al., 1982), and 
oncoproteins (Sternberg 4 Taylor, 1984). Any disturbance of 
this tight turn diminishes nucleotide binding.
The glycine at position 14 of DmADH is the first residue 
in the "conserved sequence" and represents a logical site for 
studies on the role of this "conserved sequence" in the 
structure and function of NAD-dependent dehydrogenases, in 
general, and DmADH, in specific. We have systematically 
substituted glycine 14 in DmADH with amino acids having 
progressively larger side chains, i.e., alanine and valine.
Our results show that GA14 is partially active while GV14 is 
almost inactive. GA14 is less stable than wild-type ADH at 
elevated temperature. These results are consistent with the
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fact that an EMS-induced mutant, ADH"11, which has a glycine to 
aspartate substitution at position 14, is inactive.
Furthermore, our results prove that it is the size rather than 
the charge of the mutated residue which causes the inactivation 
of EMS-induced ADH"11. Benyajati and her colleagues (1981) 
speculated that replacing glycine-14 with any larger residue 
would disturb the tight turn of the "conserved sequence", thus 
interfering with NAD binding. This view is supported by our 
results of comparing the kinetic parameters of GA14 to wild- 
type DmADH.
The kc*t/Km is an apparent second-order rate constant that 
refers to the properties of the free enzyme and free substrate, 
and the activation energy of forming the enzyme-substrate 
complex (Fersht, 1985) . The kcat/Kmtapp) value for NAD in GA14 
is five-fold lower than that of wild-type; however, the 
kcat/Km(app) value for 2-propanol is essentially unaltered.
These results indicate that the activation energy of enzyme-NAD 
binding is increased by alanine substitution; no effect on 
enzyme-alcohol binding is observed. Increased binding energy 
affects two factors: increased enzyme-NAD binding energy level, 
revealed by higher Km, and increased the activation energy for 
transition state, revealed by lower k c a t .  Increased binding 
energy should result from structural changes in the NAD binding 
domain since no charged residue has been introduced. Because 
of the structural change, some weak bonds, such as hydrogen 
bonds, may be broken, thus disrupting the correct binding of 
NAD. Inhibition studies confirm this point. The Ki of
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pyrazole for GA14 is essentially the same as that of wild-type, 
suggesting the structure of the alcohol binding domain is 
unchanged. In contrast, the inhibition caused by NADP is 
different for GA14 from that for wild-type. Noting that the 
only difference between NAD and NADP is an extra phosphate 
group on the ribose moiety of the adenine mononucleotide 
portion of the molecule, the failure of NADP to inhibit GA14 
competitively indicates that NADP does not get into the NAD- 
binding domain of the mutated DmADH.
CHAPTER FIVE
TWO "ESSENTIAL" CYSTEIMYL RESIDUES ARE MOT REQUIRED 
FOR THE CATALYTIC FUNCTION OF DmADH
It has long been thought that the two cysteinyl residues 
at position 135 and 218 in DmADH are required for catalytic 
function (Chambers, 1984). Chemical modification has been used 
to probe for the essential sulfhydryl group in this enzyme 
(Thatcher, 1981 and Chambers et al., 1981) (Section 1.2.3). 
However, results have been ambiguous and contradictory, and the 
function of these sulfhydryl groups remains obscure.
In order to distinguish the reactive cysteinyl residue 
and investigate its functional significance, we have 
constructed a series of DmADH mutants containing alanine 
substitution at cysteinyl residues 135 (CA135), 218 (CA218), 
and both 135 and 218 (CA135/CA218).
5.1 Kinetic Paraaatui
Tables 9 and 10 show the kinetic parameters of purified 
mutants and wild-type DmADH with different substrates, 2- 
propanol and ethanol. Replacement of either cysteine 135 or 
218 with alanine causes no decrease in ADH activity for 2- 
propanol or ethanol. Interestingly, the double mutant in which 
both cysteine residues are replaced by alanine (CA135/CA218) 
shows a 40% increase in activity over wild-type for 2-propanol. 
The single mutant in which the cysteine-135 residue is replace 
by alanine (CA135) shows €0% increase in activity over wild-
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type for ethanol. In contrast, the replacement of cysteine 
135, 216, or both results In unfavorable K»<*pp»s for both 
alcohols. Specifically, CA218 causes a 2-fold Increase Kmuppt 
for 2-propanol and a 4-fold Increase K*{»pp) for ethanol.
However, these mutants have no effect on the Km(app> for HAD.
The average results of a higher activity and lower binding 
affinity lead to insignificant changes of kcat/Km<«pp) values 
except mutant CA135/CA218 (Tables 9 and 10). These studies 
suggest that the two cysteine residues are not directly 
involved in the catalytic function of DmADH, but serve as 
structural residues in the alcohol binding domain.
5. 2 DTNB Modification and Inactivation of DmADH
Monitoring absorbance at 412 nm after DTNB treatment 
(Section 2.2.8) shows that the CA135 mutant has approximately 
the same sensitivity to DTNB modification as wild-type, but 
that CA218 is essentially insensitive to DTNB (Fig. 18). 
Calculations from the absorbance coefficient of TNB reveal that
1.2 moles of DTNB are converted into TNB per mole of DmADH 
monomer. This means that only one of the two cysteinyl 
residues in each monomer has been modified. This result is 
consistent with previous observations (Thatcher, 1981).
In the presence of DTNB, the wild-type enzyme and CA135, 
in which only residue 218 is cysteine, are inactivated rapidly; 
whereas CA218, in which only residue 135 is cysteine, and the 
double mutant are essentially unaffected (Fig. 19). These 
results clearly indicate that the cysteinyl residues at
Tabla 9.
XtaMapp) and koat Vfeluai of Wild-type and Mitant MADHa 
with NJU> and 2-propanol aa Subatrataa*
ENZYME
NAD
Km
mM
2-propanol
kcat
sec"1
kcat/Km 
(mM) "l (sec) '*
NAD 2-propanol
WT 0.12 ± 0.02 0.62 ± 0.09 2.90 ± 0.06 24 4.7
CA135 0.17 ± 0.01 1.17 ± 0.11 3.40 ± 0.09 20 2.9
CA218 0.15 ± 0.01 1.43 ± 0.09 3.12 ± 0.04 21 2.2
CA135/CA218 0.10 ± 0.01 1.11 ± 0.17 4.20 ± 0.08 42 3.8
‘Enzymes were assayed as described under Section 2.2.6. 
The Km(app)NM) was determined for NAD concentration between 0.1 
and 1 mM with a constant alcohol concentration of 10 mM. The 
Km ( a p p ) A i c  was measures for alcohol concentrations from 2 to 10 
mM with a constant NAD concentration of 1 mM.
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Tabla 10.
Xfe(arp) and ke«t ValiMS of Wild-typa and Mutant DnADHa 
with WU) and Kthanol aa Subatrataa*
ENZYMES Km
mM
kc*t
sec'1
kcat /Km 
(mM)-1 (sec)-1
NAD Ethanol NAD Ethanol
WT 0.12 ± 0.02 2.4 ± 0.4 1.4 ± 0.1 11.7 0.58
CA135 0.17 ± 0.01 3.1 ± 0.4 2.2 ± 0.1 12.9 0.71
CA218 0.15 ± 0.01 9.1 ± 0.6 1.1 ± 0.3 7.3 0.12
CA135/CA218 0.10 ± 0.01 6.3 ± 0.6 1.6 ± 0.4 16.0 0.25
* The enzyme assay was the same as in Table 9.
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position 218 reacts with DTNB and this leads to inactivation of 
the enzyme. Since the results of site-directed mutagenesis 
shows that this cysteinyl residue is not required for DmADH 
activity, the DTNB-induced inactivation may result from a 
steric interference in the substrate binding domain.
5. 3 Substrate Protection Studies
Figure 20 shows that DTNB modification of Cys-218 can be 
prevented by substrates, 2-propanol and NAD, indicating that 
Cys-218 is probably in or near the active site. This result is 
consistent with the significant changes with Km<app)Me for 
mutant CA218 discussed in Section 5.1. On the other hand, 
Cys-135 which normally does not react with DTNB becomes 
sensitive in the presence of NAD and 2-propanol.
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Fig. 18 DTNB modification of wild-typa and mutatad DmADH.
Enzyme (10 nmole) was mixed with DTNB (100 nmole) in 
1 ml of 0.2 M Tris-Cl buffer (pH 8.0) at 25°C. The 
absorbance at 412 nm was recorded. #, wild-type;
□ , CA135; O, CA218; CA135/CA218.
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Fig. 19 DTNB inactivation of wild-typa and mutatad DmADH.
The enzyme (4 pg) was incubated in 200 pi of 100 pM 
DTNB and 0,2 M tris-Cl buffer (pH 8.0) at 25°C. 
Aliquots of 20 pi from each sample were taken every 
3 min and assayed for ADH activity. # , wild-type; 
□ , CA135; O  , CA218; ^  , CA135/CA218.
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A
20 DTNB modification of wild-type and mutated DmADH in 
tha praaanca and abaanca of NAD and 2-propanol.
Experimental conditions were the same as those 
described in Figure 17. A: wild-type; B: CA135;
C: CA218; D: CA135/CA218. ■ , absence of
substrates; ^  , presence of 1 mM NAD; 0  ,
presence of 1 mM NAD and 10 mM 2-propanol.
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5.4 Discussion
In general, cysteinyl residues are considered potential 
catalytic sites in enzymes because of the nucleophilic nature 
of the sulfhydryl group. Previous studies on DmADH (Thatcher, 
1981 and Chambers et al., 1981) have found that this dimeric 
enzyme contains two cysteines per monomer, Cys-135 and Cys-218. 
In the native enzyme, one cysteine reacted rapidly toward DTNB 
with a concomitant loss of ADH activity. The second cysteine 
was almost unreactive toward DTNB in the native enzyme.
However, the exact position and function of the reactive 
cysteinyl residue were not determined in these studies.
In order to investigate the role of these cysteines, we 
constructed mutants of DmADH in which the cysteinyl residues at 
position 135, 218 or both are replaced by alanine. All mutants 
show identical or elevated ADH activity relative to wild-type 
enzyme. These results strongly suggest that neither of the two 
cysteinyl residues is required for the catalytic activity of 
DmADH. To further clarify DTNB reactivity of these two 
cysteines, we treated wild-type DmADH and the three mutants, 
CA135, CA218 and CA135/CA218, with DTNB. The results of these 
studies show that the mutant CA218 is insensitive to DTNB 
modification and the treated protein remains enzymatically 
active while identical experiments carried out on CA135 show 
rapid DTNB reactivity with concomitant loss of ADH activity. A 
straight-forward interpretation of these observations is that 
Cys-218 is exposed to DTNB modification while Cys-135 is 
environmentally inaccessible to DTNB. These results are
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different from previous observations (Chambers et al., 1981) 
which suggested that Cys-135 was the DTNB-reactive residue and 
found that, after chemical modification by iodoacetamide, most 
of Cys-218 was recovered as unmodified cysteine. However, Cys- 
135 was never recovered from modified enzyme for conclusive 
identification because this residue is located in a large 
hydrophobic region. On the other hand, Thatcher (1981) 
indicated that DmADH was resistant to alkylation with 
iodoacetic acid or iodoacetamide. Therefore, chemical 
modification studies offer insufficient evidence to decide 
which cysteine is the reactive residue. In contrast, site- 
directed mutagenesis, coupled with chemical modification, 
provides an unambiguous identification of the DTNB accessible 
cysteine residue in DmADH.
Inactivation of an enzyme by a chemical reagent which 
modifies certain residues is often interpreted as evidence that 
the modified residue is critical for activity. This can be 
proven only by replacement of the suspect residue with other 
appropriate residues; for example, replacing cysteine by 
alanine or serine. In papain, the necessity of an active site 
sulfhydryl group has been strongly supported by the loss of 
activity upon replacement with glycine or serine (Clark & Lowe, 
1978). In our case, replacing each cysteinyl residue with an 
uncharged alanyl residue does not alter the catalytic activity 
of this protein although chemical modification totally destroys 
the activity, suggesting that neither of the two cysteinyl 
residues in DmADH is required for catalytic function. Similar
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to our observation, Profy and Schimmel (1986) reported that 
none of the three cysteinyl residues in the ^-subunit of 
glycyl-tRNA synthetase was required for catalysis although 
enzyme activity was sensitive to N-ethylmaleimide (NEM) 
modification. They suggested that alkylation by NEM introduced 
a steric defect that led to inactivation of the enzyme. This 
probably is an appropriate explanation for our results.
The DTNB modification of Cys-218 can be prevented by the 
substrates, NAD and isopropanol, suggesting that Cys-218 may be 
in or near the active site. The kinetic studies show that 
mutant CA218 significantly alters binding affinity for both 2- 
propanol and ethanol with no effect on NAD binding. Therefore, 
we suggest that this cysteine in DmADH may play a structural or 
conformational role probably near the alcohol binding site 
rather than a catalytic role. To our surprise, Cys-135 
becomes accessible to DTNB in the presence of NAD and 2- 
propanol. It is conceivable that these substrates induce a 
conformational change which is followed by the exposure of Cys- 
135 to DTNB modification.
CHAP TBit SIX
8CHMARY
It i3 advantageous to construct an E. coll expression 
system to produce eukaryotic proteins, especially when the 
protein gene will be mutated several times and then expressed 
in varied forms. Generally speaking, an E. coll expression 
system includes a cDNA of the target protein, an expression 
vector with corresponding bacterial RNA polymerase recognition 
signals, and an E. coll host. This dissertation illustrates 
that site-directed deletion of introns in a small eukaryotic 
gene is an efficient way to obtain its cDNA. Further, 
M5219/pPL2 and LC137/pPL2/pCI857 are excellent expression 
systems for DmADH production.
By employing an E. coll expression system and site- 
directed mutagenesis, this dissertation first examines the 
structural role of glycine-14 in a "conserved sequence" which 
forms the tight turn located in the putative NAD binding 
domain. Mutating glycine-14 to valine virtually inactivates 
DmADH and alanine substitution causes a 31% decrease in 
activity, suggesting that glycine-14 is essential for DmADH 
activity. Thermal denaturation, kinetic, and inhibition 
studies confirm that replacing glycine-14 with either alanine 
or valine leads to structural changes in the NAD binding 
domain. This study provides direct evidence for the role 
played by glycine-14 in maintaining the tight turn structure. 
Replacement of glycine-14 with a residue having a bulky side
80
ei
chain disrupts the tight turn formed by the "conserved 
sequence" GlyXGlyX,Gly", thus interfering with the binding of 
HAD.
Second, this dissertation reports studies on the function 
of two cysteine residues, cysteine-135 and cysteine-218, which 
have been suggested to be catalytic residues in the enzyme. 
Substitution of one or both of these two cysteine residues by 
alanine does not affect the enzymatic activity of DmADH, 
indicating that neither of the cysteine residues is essential 
for catalysis. Chemical modification of wild-type and mutant 
proteins suggests that cysteine-218 may be in the vicinity of 
the active site and may play a structural role in the alcohol 
binding region.
In summary, site-directed mutagenesis of putative 
critical amino acid residues is an excellent tool for 
structural and functional studies of an interesting enzyme, 
such as DmADH. As mentioned in this dissertation, DmADH is 
unique among the ADHs and few of its structural and functional 
properties are known. Therefore, the results discussed in this 
dissertation about NAD binding and roles of the two cysteinyl 
residues should provide useful information about the structure- 
function relationships of DmADH.
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Appendix I 
AMINO ACID SKQOSNCK OF DwADB
Ser-Phe-Thr-Leu-Thr-Asn-Lys-Asn-Val-Ile- 
Phe-Val-Ala-Gly-Leu-Gly-Gly-Ile-Gly-Leu- 
Asp-Thr-Ser-Lys-Glu-Leu-Leu-Lys-Arg-Asp- 
Leu-Lys-Asn-Leu-Val-Ile-Leu-Asp-Arg-Ile- 
Glu-Asn-Pro-Ala-Ala-Ile-Ala-Glu-Leu-Lys- 
Ala-Ile-Asn-Pro-Lys-Val-Thr-Val-Thr-Phe- 
Tyr-Pro-Tyr-Asp-Val-Thr-Val-Pro-Ile-Ala- 
Glu-Thr-Thr-Lys-Leu-Leu-Lys-Thr-Ile-Phe- 
Ala-Gln-Leu-Lys-Thr-Val-Asp-Val-Leu-Ile- 
Asn-Gly-Ala-Gly-Ile-Leu-Aap-Asp-His-Gln- 
Ile-Glu-Arg-Thr-Ile-Ala-Val-Asn-Tyr-Thr- 
Gly-Leu-Val-Asn-Thr-Thr-Thr-Ala-Ile-Leu- 
Asp-Phe-Trp-Asp-Lys-Arg-Lys-Gly-Gly-Pro- 
Gly-Gly-Ile-Ile-Cys-Asn-Ile-Gly-Ser-Val- 
Thr-Gly-Phe-Asn-Ala-Ile-Tyr-Gln-Val-Pro- 
Val-Tyr-Ser-Gly-Thr-Lys-Ala-Ala-Val-Val- 
Asn-Phe-Thr-Ser-Ser-Leu-Ala-Lys-Leu-Ala- 
Pro-Ile-Thr-Gly-Val-Thr-Ala-Tyr-Thr-Val- 
Asn-Pro-Gly-Ile-Thr-Arg-Thr-Thr-Leu-Val- 
His-Lys-Phe-Asn-Ser-Trp-Leu-Asp-Val-Glu- 
Pro-Gln-Val-Ala-Glu-Lys-Leu-Leu-Ala-His- 
Pro-Thr-Gln-Pro-Ser-Leu-Ala-Cys-Ala-Glu- 
Asn-Phe-Val-Lys-Ala-Ile-Glu-Leu-Asn-Gln- 
Asn-Gly-Ala-Ile-Trp-Lys-Leu-Asp-Leu-Gly-
85
86
241
251
Thr-Leu-Glu-Ala-Ile-Gln-Trp-Thr-Lys-His- 
Trp-Asp-Ser-Gly-Ile
Appendix II 
Secondary Structure Prediction for DmADH 
by the Computerised Method of Chou and Pasman
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This figure is adapted from Benyajati et ai. (1981)
Appendix III
THE SEQUENCES OF SYNTHETIC OLIGONUCLEOTIDES
Synthetic oligonucleotides used as primers for 
mutagenesis and DNA sequencing.
Code Sequence (S'-3'> Start position* (nt) Remarks
Int ronl ACGAGTTCGCGCTAGACTTC
TTGGACCACTAGGAGCTGGC
Int ron11 TGAAGTGGTCGAGGGACCGC
TTTGACCGGGGGTAATGGCC
Ml3AC ACATCGATCTGCAGG
ADHECO ATGGTGAATTCTTTTGC
ADHA14 CTCCCAGAGCGGCAACG
ADHV14 CTCCCAGAACGGCAACG
ADHA13 5 CGGATCCAATGTTGGCGATG
ATACCACC
ADHA218A ACGAAGTTCTCGGCAGCCGC 
CAACGATGGCT
ADHA21SB AGCCATCGTTGGCGGCTGCC 
GAGAACTTCGT
ADHBAMA ATCTGCAACATTGGATCCGT
Ml3ECOB AAAACGACGGCCAGTGAATT
ADH2
ADH3
ADH4
ADH5
CTTCAGATCGCGCTT 
CAATGGGCACGGTCACAT 
AATGGTGCGCTCGATCTG 
CATTGAATCCAGTGACGG
79 Intron deletion
549 Intron deletion
To mutate AccI to 
Clal in Ml3 
polylinker
-17 To create EcoRI site
before the starting 
codon
36 To mutate G14 to A14
36 To mutate G14 to V14
458 To mutate C135 to
A135
To mutate C218 to 
775 A218 by PCR
775 To mutate C218 to
A218 by PCR
467 To keep BamHI site
in DmADH gene
To keep EcoRI site 
in M13 polylinker
84 Sequencing primer
258 Sequencing primer
365 Sequencing primer
483 Sequencing primer
88
ADH6 GTTCACGGTGTAAGCGGT 663 Sequencing primer
ADH7 GGCGCAGGCCAACGATGG 777 Sequencing primer
ADH8 CCAGTGCTTGGTCCACAG 873 Sequencing primer
ADH9 CTATGAACTAATGTTATG 931 Sequencing primer
ADH10 GGATTTCTCAATTTTCATA 1061 Sequencing primer
* Position No.l is base A in ATG starting codon for DmADH.
Appendix IV 
COISKM METHODS
The common solutions (including their definitions and 
compositions) and reagents used in the following procedure will 
be listed in Appendix V.
A. Site-directed Mutagenesis - Kunkel's Method
The major procedure of this method has been described by 
Kunkel et al. (1987).
i. Preparation of Uracil-Containing Tesplate
1. Inoculate two tubes containing 2.5 ml of YT medium 
with an individual colony of BW313 and grow for 6-8 
hours.
2. Prepare 100 ml YT in a 1000 ml flask with 0.25 pg/ml 
Uridine.
3. Add mid-log cells (5 ml) to the YT culture.
4. Centrifuge the M13 phage stock for 1 min, then add
100 pi to the YT culture.
5. Grow at 37°C overnight.
6. Centrifuge 5 min at 12,000 x g (9,000 rpm by JM14 
Rotor or equivalent).
7. Pour the supernatant to a clean tube.
8. Add 25 ml 20% PEG/2.5 M NaCl, vortex well, and leave
at room temperature for 1 hours.
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9. Centrifuge at the same speed for 5 min and remove 
PEG completely.
10. Resuspend the phage pellet In 2 ml TE (pH 8.0).
11. Add equal volume of buffer saturated phenol and 
vortex well. Keep at room temperature for 5 min and 
spin 2 min to separate two phases, then remove the 
upper aqueous phases.
12. Add equal volume of chloroform and vortex well.
Keep at room temperature for 5 min and spin 2 min to 
separate two phases.
13. Remove the upper aqueous phase. Add 1/10 volume of 
NaOAc (3M) and 2.5 volume of ethanol. Precipitate 
at -70°C for an hour.
14. Centrifuge 12,000 x g (10,000 rpm, JM20 rotor or 
equivalent) at 4°C for 30 min. Carefully pour off 
the ethanol.
15. Wash with 70% ethanol and dry DNA pellet under 
vacuum.
16. Dissolve the pellet in 0.5 ml TE (pH 6.0).
II. Xn Vitro Mutagenesis
1. Phosphorylation of mutagenic primer
Kinase reaction buffer 10X 2 pi
ATP (10 mM) 2 pi
Mutagenic primer (1.5 pmole) x pi
Distilled H20 y pi
T4 DNA kinase (3 u/pl) 1 pi
Total Volume: 20 pi
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Incubate the reaction mixture at 37°C for 1 hour and stop 
by adding 0.6 pi EDTA (0.5 M).
2. Hybridization of phosphorylated primer to the 
uracil-containing template
To the kinase reaction mixture, add 0.3 pmole 
uracil-containing template and 1.2X SSC. Heat it in 
65BC water bath for 30 min, then cool down to room 
temperature slowly. Keep the reaction mixture on 
ice.
3. In Vitro DNA synthesis 
To the annealed template, add:
Hepes (0.1 mM, pH 7.8) 20 Pi
DTT (1 M> 0.5 Pi
MgCl2 (1 M) 1 Pi
dNTP (100 mM) 0.5 Pi
ATP (10 mM) 1 Pi
DNA polymerase
(Klenow) (5 u/pl) 0.5 Pi
T4 polynucleotide
Ligase (1.4 u/pl) 2 Pi
Distilled H2O X Pi
Total Volume: 100 Pi
Keep the above mixture in ice bath for 5 min. 
Keep in room temperature for 5 min, then incubate at 
37°C for 2 hours. Stop the reaction by adding 3 pi 
EDTA (0.5 M).
4. Product analysis
Load 20 pi of the reaction solution on 0.8% TAE 
agarose gel. Run the electrophoresis at 20 volts 
for overnight. The known single strand DNA and
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for overnight. The known single strand DNA and 
double strand DNA can be used as markers.
I I I .  Preparation of Competent Cells and Transformation
The transformation technique has been discussed by 
Hanahan <1983).
1. Dilute the overnight CSH50 cell culture (YT) by 
ratio of 1:100 into a 50 ml YT medium and grow at 
37°C for 2.5 hours.
2. Cool the cells on ice for 15 min.
3. Spin 25 ml at scale 7 for 15 min in cold room.
4. Resuspend in 8 ml ice cold TFB and place on ice for
30 min.
5. Repeat step 3.
6. Resuspend in 2 ml cold TFB.
7. Add 70 pi of DMSO and keep on ice for 5 min.
8. Add 70 pi of DTT <2.25 M) and keep on ice for 10
min.
9. Repeat step 7.
10. Transfer 200 pi competent cells to each sample tube.
11. Add 1 pi the diluted (1:5 by TE) reaction mixture
from in vitro mutagenesis step I1-3 to competent 
cells.
12. Incubate on ice for 30 min.
13. Heat shock cells at 42°C for 90 sec and chill on ice.
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14. Mix the sample with 3 ml soft agar (at 47°C)
containing 50 pi 2% x-gal and 10 pi 100 mM IPTG , 
pour the mixture immediately onto a YT plate, and 
incubate at 37eC overnight.
IV. Plaque Hybridisation and Screening of Mutations
The major steps of this protocol is described by Seong & 
RajBhandary (1987).
1. Choose a plate that has 100-200 plaques and chill 
for 30 min at 4°C.
2. Lay a dry nitrocellulose filter onto the agar and 
let the phage adsorb for 5 min.
3. Mark the filter by stabbing an inked needle through 
filter.
4. Carefully peel the filter and air dry the filter for 
5 min on a sheet of Whatman 3 MM.
5. Wet a sheet 3MM paper with 0.5 N NaOH/1,5 M NaCl. 
Roll off the excess liquid with a pipet.
6. Place the filter onto the paper with plaques facing
up and stand for 5 min. Remove and air dry for 2
min.
7. Repeat step 6.
8. Place the filter onto a sheet of 3MM paper soaked
with 1 M Tris-Cl (pH 8.0) and let stand for 5 min.
Remove and dry 2 min.
9. Repeat step 8.
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11. Hash the filter in 100 ml 6X SSC for 2 min and air 
dry.
12. Bake in vacuum oven for 1 hour at 80°C.
13. Place the filter (plaques facing up) into the petri- 
dish filled with 5 ml pre-hybridisation solution.
14. Swirl to completely wet the filter, cover and 
incubate at 37°C for 1 hour.
15. Pour off pre-hybridization solution and add 5 ml 
probe (”P labeled mutagenic primer) solution in the 
same petri-dish and incubate at room temperature 
overnight.
16. Remove the probe solution and save it in -20°C.
17. Wash the filter in 100 ml 6X SSC for 15 min, 
repeating 3 times at room temperature.
18. Wrap the filter in saran wrap and develop 
autoradiography for 3 hours with an intensifier at 
—70°C.
19. Briefly wash in 3 M (CHa) <NC1 at room temperature 
about 3 min. Hash the filter in an appropriate 
temperature [4-5°C below Td in (CH3)<NC1].
20. Remove the filter and check the signal with Geiger 
counter, if the signal is still high, then raise the 
temperature by 2°C and wash it again. Repeat washing 
until the signal become weak.
21. Air dry the filter and autoradiography overnight.
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22. Comparing the film developed before washing with the 
one after washing, the mutation should be 
identified.
In addition to this method, a mutation can also be 
identified by DNA sequencing (see Appendix Four, Section F ).
B. Site-directed Mutagenesis - Polys rase Chain Reaction 
(PCR)
These procedures are modified methods developed by 
Higuchi et al. (1988) and Perkin-Elmer Cetus in the catalog of
"GeneAmp DNA Amplification Reagent Kit".
I. Producing two DMA fragments with the same mutation site 
which is at 3' end of one fragment (fragment A) and 5' end of 
another (fragment B) .
1. Purify two pairs of synthetic primers (A-3'& A-5', 
B-3' & B-5'). Their purification will be described 
in Appendix IV section E.
2. The reaction mixture:
Reaction buffer 10X 25 Pi
dNTPs (1.25 mM) 40 Pi
Primer 1 (A-3' or B-3') (50 pmole) X Pi
Primer 2 (A-5' or B-5') (50 pmole) y Pi
Template DNA (0.3 pmole) z Pi
Double-distilled H2O w Pi
Taq DNA polymerase (5 u/pl) 1.3 Pi
Total Volume: 250 pi
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3. PCR reactions are performed in a Perkin-Elmer Cetus 
DNA Thermal Cycler. Each cycle consists of 
denaturation at 94°C for 2 min, annealing at 37°C for 
1 min, and extension at 72°C for 2.5 min. Twenty 
cycles are performed. Extension time of the last 
cycle is 10 min to ensure that all single stranded 
DNA have been copied or re-annealed to form double 
strands.
4. The products are extracted once with 100 pi 
chloroform.
5. The two DNA fragments produced are purified by 
agarose gel electrophoresis followed by elution as 
described by Maniatis et al. (1982).
6. Extract the eluate with water saturated 1-butanol 
once and ethanol precipitate at -70°C overnight.
7. Hash with 70% of ethanol and dry DNA pellets.
8. Dissolve the pellets in 50 pi TE <pH 8.0).
II. Connection of the two DNA fragments at mutation site by 
the second round of PCR
1. Mix the two DNA fragments with the primer A-5' and
B-3'. The reaction conditions are exactly the same
as the step 1-3.
2. Extract the reaction mixture with chloroform once.
3. Extract the reaction mixture with phenol once.
4. Precipitate with ethanol at -70"C overnight.
5. Wash with 70% of ethanol and dry the pellet.
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6. Dissolve in 10 pi TE (pH 8.0) and check the size and 
purity of produced DNA by agarose gel 
electrophoresis.
7. The PCR produced DNA fragment which contains a 
desired mutation can be linked to a DNA vector by 
appropriate restriction sites.
C. Preparation of Plasmid and Phage DMA Vector
I. Mini-preparation Procedure
This protocol was similar to the alkaline lysis method 
described by Maniatis at al. (1982).
1. Pour 1.5 ml of over night cell culture [E. coll with 
plasmid or infected with bacteria phage (for Ml3, 
see sequencing template preparation)] into an 
eppendorf tube. Centrifuge for 5 min at room 
temperature.
2. Drain the supernatant, leaving the pellet as dry as 
possible.
3. Resuspent the pellet in 100 pi of ice-cold solution 
I and keep at room temperature for 5 min.
4. Add 200 pi of fresh made ice-cold solution II. Mix 
the contents by inverting the tube rapidly. Do not 
vortex. Keep it on ice for 5 min.
5. Add 150 pi of ice-cold solution III. Mix it by 
inverting tube rapidly for five times. Keep it on 
ice for 10 min.
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6. Centrifuge at 4°C for 10 min and transfer the 
supernatant to a fresh tube.
7. Add 0.5 ml of phenol/chloroform (1:1), vortex, and 
stand for 2 min. Centrifuge at room temperature for 
2 min and transfer the supernatant to a fresh tube.
8. Add 1 ml ethanol at room temperature, keep it at 
room temperature for 5 min, and centrifuge at room 
temperature for 5 min.
9. Remove the supernatant. Stand the tube in an 
inverted position on a napkin to allow all of the 
fluid to draw away.
10. Wash the pellet with 1 ml of 70% ethanol and re­
centrifuge at room temperature for 5 min.
11. Remove ethanol and dry the pellet briefly by vacuum.
12. Dissolve the DNA in 60 pi TE (pH 8.0). Take 10 pi 
for digestion assay.
II. Large-Scale Preparation without using CsCl centrifugation
This protocol is the modified protocol from Barttlet 
(personal communication).
1. Inoculate 2.5 ml LB broth containing an appropriate 
antibiotic or 2.5 ml YT with a single colony, and 
grow 8-12 hours.
2. Transfer 2.5 ml liquid cell culture (LB or YT) to 
250 ml LB with a same antibiotic or 250 ml YT plus 
500 pi M13 stock and incubate it at certain 
temperature (37°C or otherwise specified overnight.
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3. Chill the culture for 15 min.
4. Pellet cells 6,000 x g (5000 rpm, JM14 rotor or 
equivalent) at 4°C for 15 min.
5. Resuspend the cell pellet in 5 ml solution I, then 
transfer to an 40 ml tube.
6. Add 1 ml lysozyme solution (12 mg/ml in solution I) 
to the final concentration of 2 mg/ml. Incubate on 
ice for 20 min.
7. Add 12 ml ice cold solution II and incubate on ice 
for 10 min.
8. Add 8 ml solution III and stand on ice for 20 min.
9. Centrifuge 39,100 x g (18,000 rpm, JM20 rotor or 
equivalent) for 30 min at 4°C and transfer the 
supernatant to two 50 ml Polypropylene Centrifuge 
Tubes.
10. To each Polypropylene Centrifuge Tube, add 5 pi (10 
mg/ml) DNase-free RNase A. Incubate at 37°C for 40 
min.
11. Extract each tube twice with equal volume of 
phenol/chloroform (1:1, v/v). Spin in large bench 
centrifuge for 15 min.
12. Transfer the aqueous phase to Corex tubes. Add two 
volumes of ethanol. Precipitate DNA on ice for 30 
min.
13. Spin 12,000 x g (10,000 rpm, JM20 rotor or 
equivalent) at 4“C for 30 min.
14. Dissolve the pellets in total 1 ml double distilled 
Ha0, then wash all the tubes by 0.6 ml double 
distilled HaO. To total 3.2 ml add 0.64 ml 5 M NaCl 
and 4 ml 13% PEG and incubation on ice for 1 hour.
15. Pellet DNA by centrifuge 12,000 x g (10,000 rpm,
JM20 rotor or equivalent) at 4°C for 30 min.
16. Hash pellet with 70% ethanol.
17. Completely dry the pellet under vacuum and dissolve 
DNA in TE (pH 8.0).
Subcloning of DMA Fragments
Isolate the DNA fragment from low melting gel
1. Prepare 1% low melting gel (SeaPlaque) in 50 mM 
Tris-acetate (TAE) buffer. It should be cooled to 
37°C before pouring.
2. After sample DNA and vector are digested with
certain enzymes, inactivate the enzymes by heating
or EDTA and keep in ice if they are heat treated.
3. Prior to loading the sample the gel should be pre­
run for at least 10 min. During this pre-run the 
voltage should be slowly increased to the required 
setting (5-7 V/cm).
4. After electrophoresis of the DNA, specific fragments 
can be localized by staining the gel for 10 min with
0.2 pg/ml ethidium bromide (2,7-Diamino-10-ethy1-9- 
phenylphenanthridium bromide) and visualized with 
long wave length UV light.
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II. Ligation reaction
1. Gel slices containing specific fragments can be cut 
out and melted at 70“C for 10 min and kept in 37°C.
2. Protocol for ligation reaction:
Vector DNA x pi (mole of Vector : mole of Insert
- 1:2)
insert DNA y pi (x + y - 10 pi)
double distilled 
H20 5 pi
lOx ligation
buffer 4 pi
T4 DNA ligase
<2 u/pl) 1 pi
Total Volume: 20 pi
The reaction mixture is incubated at 158C for 12-20 hours.
III. Transformation (BRL protocol #8264SA for DH5*F' cocqpetent 
cell)
1. Remove competent cells and lawn cells from freezer; 
thaw on ice.
2. Transfer 50 pi to a polypropylene tubes and the 
remaining should be refreezed in the dry ice/ethanol 
bath for 5 min, then returned to -70“C freezer.
3. Dilute the ligation mixture 5 times with TE (pH 8.0)
and transfer 1 pi to competent cells.
4. Mix them gently and incubate on ice for 30 min.
5. Heat-shock cells 45 sec in a 42°C water bath.
6. place on ice for 2 min.
7. Add the transformed competent cells to 3 ml top agar
(YT or LB) containing 50 pi lawn cells, 50 pi 2% x- 
gal and 10 pi 100 mM isopropyl- -D-hiogalacto-
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pyranoside (IPTG) (x-gal and IPTG are required only 
for the vector containing Q-glacosidaes gene) and 
plate on agar plates.
8. Incubate the plate at 37°C overnight.
9. Identify the correct colonies by mini-preparation of
DNA followed by restriction enzyme digestion and gel
electrophoresis.
E. Purification of Synthatic Oligonucleoel.de
This is a modified protocol described in the catalog of 
"Oligonucleoside Purification Cartridges” from Applied 
Biosystems.
1. Flush the cartridge with 5 ml HPLC grade 
acetonitrile, followed by 5 ml 2.0 M triethylamine 
acetate. Keep the flow rate at 1 drop/second.
2. Load the crude synthetic oligonucleoside into the 
syringe which is connected to the cartridge and then 
gently push through the cartridge. Save the eluted 
fraction and reload this fraction second time.
3. Flush cartridge with 5 ml diluted ammonium hydroxide 
(1:10 dilution of 30% pure ammonium hydroxide in 
deionized water) for 3 times.
4. Hash cartridge with 5 ml deionized water for twice.
5. Detritylated the support-bound oligonucleoside with 
5 ml of 2% trifluoroacetic acid solution twice.
6. Flush cartridge with 5 ml deionized water twice.
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7. Elute the purified, detritylated oligonucleoside by 
flushing the cartridge with 3 ml of the 20% 
acetonitrile solution.
8. Evaporate to dryness an aliquot of the eluate and 
dissolved in 2X TE (pH 8.0).
9. The purity of the oligonucleoside can be checked by 
kinase reaction with 3,P and autoradiography.
F . DMA sequencing
I. Preparation of Teaplate DMA
This protocol was described by Sanger et al. (1977). It 
has been used to prepare template DNA for sequencing. The DNA 
template prepared from this procedure is sufficiently pure for 
sequencing uses.
1. Inoculate one tube containing 2 ml of YT medium with
a single colony of DH5 F' and grow at 37°C for
overnight
2. Transfer 30 pi overnight cell culture to 3 ml YT and 
add 7.5 pi supernatant of stock phage culture to the 
same YT containing tube.
3. Grow cells at 37°C for 5.5 hours with shaking.
4. Transfer 1.5 ml of the culture to an eppendorf tube
and centrifuge for 5 min.
5. Pour the supernatant to a clean eppendorf tube 
taking care not to carry over any cells and add 200 
pi of 20% PEG/2.5 M NaCl.
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6. Vortex the supernatant well and leave them at room 
temperature for 30 min.
7. Centrifuge the tubes for 5 min and remove all 
residual supernatant completely.
8. Resuspend the phage pellets and combine two tubes in 
100 pi of TE {pH 8.0) .
9. Add an equal volume of buffer saturated phenol,
vortex well, and leave for 5 min. Vortex and
centrifuge for 2 min.
10. Transfer upper aqueous layer to a new tube and add 
1/10 volume of NaOAc (3 M), 2.5 volume of ethanol 
and precipitate at -70°C for 30 min.
11. Centrifuge for 30 min at 4°C and carefully pour off 
the ethanol.
12. Wash the pellet with 70% ethanol and vacuum dry.
13. Redissolve the pellet in 25 pi of TE (pH 8.0) and 
store at -20°C.
14. Take 3 pi to run a 0.8% agarose gel to check the
purity and concentration using a known concentration
phage DNA as the standard.
11. Preparation of 6% Polyacrylamide Gel
This procedure is modified from Ml3 cloning and 
sequencing manual (BRL).
1. Carefully clean one pair of glass gel plates with 
detergent.
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2. Siliconize (Sigma-coat) the inside of the smaller 
plate by wiping with glass wool socked with 5% 
solution of dichlorodimethylsilane in chloroform and 
allow to air dry. Hash away the remaining 
siliconizing solution with water and dry the plate 
again. The siliconized plate is good for at least 5 
uses.
3. Right before use, wipe clean with 95% ethanol.
4. Assemble the glass plate using side spacers and 
bulldog clamps and keep it horizontally.
5. For 50 cm x 20 cm gel, measure 60 ml of 6% 
acrylamide stock solution and degas for 15 min.
6. Initiate polymerization by adding 45 pi TEMED and 
240 pi 10% ammonium persulfate.
7. Mix the acrylamide solution well and pour to the 
plate as quick as possible. Put the comb in place. 
The gel should polymerize after 5 min and within 20 
min.
8. Cover both top and bottom of the gel with saran wrap 
and store it for overnight.
III. Dideoxy Sequencing Reaction
Routinely a Sequenase Kit purchased from USB INC is used.
The following protocol is described in USB procedure.
1. Annealing Mixture
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For each sample:
Template DNA (1-2 pg) x pi 
Primer DNA (2.5-3 ng) y pi
distilled H2O 
Buffer 5x
z pi 
2 pi
Total Volume 10 pi
Anneal by heating the mixture at 70°C water and cool 
slowly to < 35°C.
2. While cooling, fill the pre-labeled tube with 2.5 pi 
of each Termination Mixture (ddNTP) and pre-warm at 
37°C water bath.
3. Dilute the Labeling Mix 1 : 5 by distilled H20.
4. Pre-cool TE (pH 7.5) for dilution of sequenase.
5. Labeling Reaction
To Annealed DNA Mixture (10 pi), add
DTT (0.1 M) 1 pi
Diluted labeling mix 2 pi
[“S] dATP 0.5 pi
Diluted Sequenase 2 pi
Total Volume: 15.5 pi
Incubate at room temperature for 5 min.
6. Termination Reaction
Transfer 3.5 pi of labeling reaction to each 
termination mixture and incubate at 37°C for 5 min.
7. Stop by adding 4 pi stop solution. The sequencing
mixture can be store at -20°C for a few weeks.
IV. Gel Electrophoresis and Poet-treatment
1. Pre-run the gel at 45 watts for 30 min.
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2. Heat the samples In a 90°C water bath for 5 min, then 
quickly load appropriate amount to the gel. Run at 
the same watts until the fast dye reaches the bottom 
of gel.
3. Carefully separate two glass plates using spatula,
leave gel lying on the larger plate.
4. Fix the gel in 10% Methanol/10% Acetic Acid for 30
min.
5. Cover the gel with two sheets of 3MM paper and
invert the glass plate to transfer the gel to the 
3MM paper.
€. Cover the gel with saran wrap and dry the gel at 80°C 
for 0.5-1.0 hours on a gel dryer.
7. Place a sheet of X-ray film on top of the gel and
expose at room temperature overnight.
G. Purification of Dxoagpbiia ADH froa K . coll Boat
I. Bacteria Cell Lysis
1. One liter of Transformed cells at late log phase are 
pelleted at 4°C, 7,000 x g (7,000 rpm, JM14 rotor or 
equivalent), 30 min and resuspended at 10% by weight 
in sonication buffer.
2. Sonication is performed on ice, using a Horn tip at 
level 6, pulse, and 50%. The cell solution is 
sonicated for 2 min, cooled for 2 min, and then the 
same action is repeated twice.
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3. Spin the cells at 27,000 x g (15,000 rpm, JM20 rotor 
or equivalent) at 4°C for 30 min.
4. Resuspend the pellet in 10-15 ml sonication buffer 
and repeat the sonication again.
5. Repeat step 3 and measure the final volume of the 
supernatant.
II. Ammonium sulfate precipitation
1. To the crude extract, add solid (NH4)2SOi very slowly
to 40% saturation and allow 15 min on ice.
2. Centrifuge 27,000 x g (15,000 rpm, JM20 rotor or
equivalent) and measure the volume of supernatant.
3. To the supernatant, add solid (NHO2SO4 very slowly 
to 60% saturation and keep it at 4°C for at least 2 
hours.
III. Sepbadex G-100 Column
1. A Sephadex G-100 column (size: 2.5 x 120 cm) has 
been packed one day before running, using column 
buffer saturated and degassed Sephadex G-100 (40 g).
2. The column should be pre-equilibrated at running 
flow rate (30 ml/hr) overnight in cold room.
3. Check the conductivities of the equilibration buffer
and eluate to determine if the column is 
equilibrated.
4. Calibrate the column by 2 ml blue dextran (2 mg/ml).
IV.
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5. The precipitated protein is centrifuged at 27,000 x 
g (15,000 rpm, JM20 rotor or equivalent) for 30 min 
and dissolved in 5 ml column running buffer.
6. Load the protein onto the column and allow it runs 
into Sephadex. Hash the column with column running 
buffer.
7. Collect the eluate and measure protein concentration 
by UV absorbance at 280 nm.
8. Each collected eluate (about 5 ml) is also assayed 
for ADH activity (see Appendix IV-H).
9. Eluted fractions containing the majority of ADH 
activity are pooled and applied to a Cibacron Blue 
3GA-Agarose column.
Cibacron Blue 3GA-Agaroae Column
1. Cibacron Blue 3GA-Agarose (20 g) is suspended in 
column running buffer and gently stirred at 4"C to 
break any clumps for at least 1 hour.
2. Transfer the resin to the column (2.5 x 20 cm) 
without trapping air bubbles.
3. The column is equilibrated at 48C with column running 
buffer by the flow rate 24 ml/hour overnight.
4. Check the conductivities of the equilibration buffer 
and the elate to determine if the resin is 
equilibrated.
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5. Load the protein onto the column and wash with
column running buffer until the absorbance of the
eluate at 280 nm is almost zero.
6. Use a BRL gradient former to make a linear NaCl 
gradient (0 - 2 M). The inner cylinder of the 
gradient former is filled with 200 ml column buffer 
and the outer is filled with the same buffer 
containing 2 M NaCl.
7. Elute proteins by the linear NaCl gradient, collect
eluate, and assay for ADH activity.
8. The fraction which contain the majority of ADH 
activity can be dialyzed and concentrated in an 
Amicon ultrafiltration cell.
9. The purity of the collected ADH protein is 
determined by using a 10% SDS-PAGE.
H. ADH Activity Assay
The assay condition is designed by Lee (1982).
Assay solution (1 ml):
Tris.Cl (pH 9.8) (1 mM) 100 pi
NAD (100 mM) 10 pi
Alcohol (d-0.78 g/ml) €4 pi
Double distilled H2O x pi
ADH protein y pi
Total Volume: 1000 pi
The reaction is started by adding ADH and the absorbance 
at 340 nm is recorded by spectrophotometer (Gilford-Response 
II). One unit of activity is defined as a change in absorbance 
at 340 nm of 0.001 per min (Sofer & Ursprung, 1968).
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I. Ptottln Assay
The protein assays in this project are performed by using 
Bio-Rad protein assay solution. The principle and reagent of 
the assay solution are described in Bio-Rad catalog.
1. Dilute Bio-Rad protein assay solution by distilled 
H2O (1 : 5, v/v).
2. Make assay standards by BSA of known concentration 
<2, 4, 6, 8, and 10 pg/100 pi). Add each of the 
standard BSA of 100 pi to 5 ml diluted assay 
solution and take 1 ml for the assay.
3. Record the absorbance at 595 nm of each standard to 
create a standard curve on spectrophotometer 
(Gilford-Response II).
4. Assay unknown proteins at the same conditions as the 
BSA standards.
j. Western Blot Protein Analysis
The procedure of western blot on ADH has been described 
by Batzer efc al. (1988).
1. Make up 4 liters of transfer buffer and keep it at 
4*C.
2. Saturate the filter paper, sponge pads, and blotting 
membranae in transfer buffer for 30 min.
3. Saturate SDS-PAGE in transfer buffer for 30 min.
4. In blot holder, layer the following in the order of 
sponge pad, filter paper, SDS-PAGE, blotting
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membranae, filter, and sponge pad. Insert them into 
apparatus so that blotting membranae side is toward 
the anode.
5. Fill the apparatus with transfer buffer and run at 
30 volts for 7 hours.
6. Sock the membranae in blocking solution at 4°C 
overnight.
7. Incubate blotting membrane with anti-ADH antibody 
that is diluted (1:10) with blocking solution (about 
5 ml) at 4°C overnight.
6. Wash membrane 6 times with Dubiccos phosphate
buffer. Each wash for at least 15 min at room 
temperature.
9. Incubate blotting membrane with alkaline phosphatase 
conjugated anti-rabbit IgG that is diluted (1:1000) 
in blocking solution (250 ml). Leave it overnight 
at 4°C.
10. Wash the membrane 6 times with Dubicoos phosphate 
buffer. Each for at least 15 min at room 
temperature.
11. Incubate the membrane with substrate solution.
Starts visualization in about 10 min. When 
completely developed pour away substrate solution 
and put the membrane in distilled water.
12. Dry the membrane at room temperature.
Appendix V 
Cowon Solutions/Reagents
Btctarii H i d l w
LB (Luria-Bertani) per liter Bacto-tryptone 10 g
Bacto-yeast 5 g
NaCl 5 g
Adjust pH to 7.5.
for plate Bacto-agar 15 g
for top agar bacto-agar 7 g
YT Medium per liter Bacto-tryptone 8 g
Bacto-yeast 5 g
NaCl 5 g
Adjust pH to 7.5.
for plate Bact-agar 15 g
for top agar Bact-agar 7 g
DMA buffers
TE (Tris-EDTA) 10 mM Tris-Cl (pH 8.0)
1 mM EDTA
TBE (Tri s-Borate-EDTA) Per liter lOx stock solution
Tris base 121 .1 g
Boric acid 55 g
EDTA 7.4 g
Adjust pH to 8.0.
TAE (Tris-Acetate-EDTA) Per liter 50x stock solution
Tris base 242 g
Glacial acetic acid 57.1 ml
0.5 M EDTA (pH 8.0) 100 ml
Adjust pH to 8.0.
Transformation reagents
100 mM IPTG 23.8 mg IPTG/ml in H2O (MW. 238.3),
store at -20“C.
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X-gal 2% solution 25 mg in 1.25 ml DMSO, store at 4°C in 
a dark bottle.
1 M K-MES (pH €.3) 9.76 g in 50 ml H2O (MW. 195.2) using 
10 M KOH to adjust pH to 6.3, filter, 
store at -20°C.
TFB (Transformation 
buffer)
2.25 M DTT
10 mM K-MES (pH 6.3), 100 mM RbCl, 
45 mM MnCl2.4H20, 10 mM CaCl2.2H20,
3 mM HAC0CI3, filter, store at 4“C.
347 mg in 1 ml 40 mM KAC (pH 6.0) 
(MW. 154.3), filter, store at -20°C,
Plaque hybridisation solutions
20 X SSC 175.3 g of NaCl and 88.2 g of Tri­
sodium citrate in 800 ml of H2O.
Adjust pH to 7.0 with a few drops of
HC1. Adjust volume to 1 liter.
50 X Denhart's solution For 500 ml stock solution
Ficoll 5 g
PVP 5 g
BSA (Pentax Fraction V) 5 g
Add H2O to 500 ml
Filter through a Nalgene filter. 
Dispense into 25 ml aliquots and store 
at —20“C.
Prehybridization solution 6 X SSC, 10 X Denhart's,
and 0.1 % SDS.
Hybridization solution 6 X SSC, 10 X Denhart's,
and 5 x 10’ cpm probe.
Plasmid preparation solutions
Solution I 
Solution II 
Solution III
50 mM glucose, 25 mM Tris-HCl (pH 
8.0), 10 mM EDTA.
0.2 N NaOH, 1 % SDS (use and made 
freshly)
To 60 ml of 5 M potassium acetate add
11.5 (5 M KOAc) ml of glacial acetic 
acid and 28.5 ml H20. The resulting 
solution is 3 M with respect to 
acetate (pH 4.8).
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Polyacrylamide gel electrophoresis (FJUZK)
The following PAGEs are prepared from 40% acrylamide (ACRYL-40) 
and 2 % bis-acrylamide (BIS-2) stock solutions (American 
Research Products Company).
6% Sequencing gel per 250 ml
(Stock Solution) ACRYL-40 35.6 ml
BIS-2 37.5 ml
urea 115 g
10 X TBE 12.5 ml
Add H2O to 250 ml
20 % Oligomer purification gel per 120 ml
ACRY-40 57 ml
BIS-2 60 ml
urea 20 g
10 X TBE 12 ml
Add H2O to 
degas 15 min 
Add 10 % Ammonium
250 ml
persulfate 300 pi
TEMED 60 pi
10 % SDS protein gel per 50 ml
ACRY-40 12.5 ml
BIS-2 5 ml
urea 1.5 g
10 % SDS 0.5 ml
1 M phosphate 5 ml
Add H2O to
10 % Ammonium
50 ml
persulfate 260 yl
TEMED 65 pi
SDS-PAGE running buffer 0.1 M phosphate (pH 7.4), 0.1 %
SDS, and 1.76 ml of thiolatic
acid. Adjust pH to 7.4 by NaOH
and add H2O to 2 liters.
SDS-PAGE fixing solution 50 % methanol and 10 % acetic 
acid
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SDS-PAGE staining solution
SDS-PAGE destaining solution 
5 X SDS-PAGE sample buffer
per 500 ml
coomaisse brillant 
blue R—250 1.25 g
acetic acid 21 ml
methanol 227 ml
H20 227 ml
Stirring for 1 hour and 
filtrate through whatman 
filter.
25 % methanol and 7.5 % acetic 
acid
300 mM phosphate buffer
(pH 7.4), 50 % glycerol, 250 mM
DTT, 0.125% BPB, and 10 % SDS.
Cellophane treatment solution 5 % NaC02 and 50 mM EDTA. Boil
for 5 min and rinse in 
distilled H2O.
Protein purification solutions
Sonication buffer 50 mM phosphate, 1 mM DTT, 0.1
mM EDTA, and 0.1 mM PMSF (0.2 M 
stock solution in ethanol)(pH 
7.4).
Column buffer 50 mM tris-Cl and 1 mM EDTA (pH
8.3) .
VCsstsrn blot solutions
Transfer buffer 2 mM sodium acetate, 5 mM MOPS 
(pH 7.5), and 20 % (v/v) 
ethanol.
10 X Dulbiccos
Blocking solution 
(1 liter)
For 1 liter
KC1 2 g
KH2PO4 2 g
NaCl 80 g
Na2HP04 11.3 g
Sodium Azide 1 g
(0.08 M)
1 X Dulbiccos buffer, 50 g 
Carnation non-fat dry milk, 
and 0.5 g sodium azide.
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Substrate solution 1. 50 pi 5-bromo-4-chloro-3-
indolyl (BC1P) stock solution. 
(The stock solution is
100 mg/ml BCIP in imethyl- 
sulfoxide and stored at 
-20°C) .
2. 10 ml nitro blue
tetrazolium (NBT) stock 
solution (The stock solution 
is 1 mg/ml NBT in H2O stored 
at 4°C) .
3. 90 ml tris buffer (100 mM
tris, pH 8.8; 1 mM MgCl2) .
Appendix VI
DmAdh Sequence end Cndonucleeae Cutting Sites
This gene map was generated from the Sequence Analysis 
Software Package of the Genetic Computer Group (GCG)
(University of Wisconsin Biotechnology Center).
KEYWORDS alcohol dehydrogenase; dehydrogenase.
SOURCE drosophila melanogaster (adh-s and adh-f) cdna ([1]) and dna . . .
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